RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Poisoning
Accession: DOID:9000046
browse the term
Definition: A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent.
Synonyms: exact_synonym: Poisonings
related_synonym: Benzene toxicity, susceptibility to
primary_id: MESH:D011041
xref: EFO:0008546
G
ABCB1
ATP binding cassette subfamily B member 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:23562926
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ACHE
acetylcholinesterase (Yt blood group)
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17098105 PMID:19453088
RGD:5688054
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
ALB
albumin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:10511253
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
BCHE
butyrylcholinesterase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:20176007 PMID:20513442 PMID:21620937 PMID:21683774 PMID:29183815
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
CDKN2A
cyclin dependent kinase inhibitor 2A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20044985
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
G
CDKN2B
cyclin dependent kinase inhibitor 2B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20044985
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
G
CSF3
colony stimulating factor 3
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:15727166
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
G
CST3
cystatin C
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22525860
NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473
G
CYP4F3
cytochrome P450 family 4 subfamily F member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20036648
NCBI chr19:15,640,897...15,662,825
Ensembl chr19:15,640,897...15,662,825
G
EPO
erythropoietin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:15727166
NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
G
GCG
glucagon
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:7629900
NCBI chr 2:162,142,882...162,152,247
Ensembl chr 2:162,142,882...162,152,404
G
GSK3B
glycogen synthase kinase 3 beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22975441
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
HAND1
heart and neural crest derivatives expressed 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21964422
NCBI chr 5:154,474,972...154,478,227
Ensembl chr 5:154,474,972...154,478,227
G
IL1A
interleukin 1 alpha
treatment
ISO IDA
RGD
PMID:1868253 PMID:2258610
RGD:11051971 , RGD:11059514
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
NQO1
NAD(P)H quinone dehydrogenase 1
IAGP
ClinVar Annotator: match by term: Benzene toxicity, susceptibility to
ClinVar
PMID:1737339 PMID:6933553 PMID:9000600 PMID:9230185 PMID:9328142 PMID:9593466 PMID:9855009 PMID:10393869 PMID:10393963 PMID:18511948 More...
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
PRKDC
protein kinase, DNA-activated, catalytic subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20036648
NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178
G
SLC22A2
solute carrier family 22 member 2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:22525860
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
G
XIRP1
xin actin binding repeat containing 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21964422
NCBI chr 3:39,183,215...39,192,595
Ensembl chr 3:39,183,210...39,192,596
G
CCK
cholecystokinin
susceptibility
IAGP
DNA:SNP:promoter: -45C>T (human)
RGD
PMID:10235270
RGD:406351024
NCBI chr 3:42,257,826...42,266,185
Ensembl chr 3:42,257,825...42,266,185
G
CNR1
cannabinoid receptor 1
IAGP
RGD
PMID:11841893
RGD:1626329
NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
G
NGF
nerve growth factor
IEP
protein:increased expression:serum
RGD
PMID:17434673
RGD:401965399
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
PTGS2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:16318954
RGD:5688289
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
SLC6A3
solute carrier family 6 member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
G
CACNA1D
calcium voltage-gated channel subunit alpha1 D
susceptibility
ISO
mRNA, protein:increased expression:inferior colliculus (rat)
RGD
PMID:25556199
RGD:152985539
NCBI chr 3:53,494,611...53,813,733
Ensembl chr 3:53,328,963...53,813,733
G
DRD2
dopamine receptor D2
susceptibility
IAGP
DNA:SNP:exon:A>G(human)
RGD
PMID:23238469
RGD:401959213
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
PDYN
prodynorphin
ISO
mRNA:increased expression:brain
RGD
PMID:15869750
RGD:401850576
NCBI chr20:1,978,756...1,994,285
Ensembl chr20:1,978,757...1,994,285
G
SLC29A1
solute carrier family 29 member 1 (Augustine blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283641
NCBI chr 6:44,219,615...44,234,142
Ensembl chr 6:44,219,553...44,234,142
G
SLC6A3
solute carrier family 6 member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27219321
NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
G
AIF1
allograft inflammatory factor 1
ISO
protein:increased expression:cortex, hippocampus (rat)
RGD
PMID:18585922
RGD:2313030
NCBI chr 6:31,615,234...31,617,015
Ensembl chr 6:31,615,217...31,617,021
G
CIRBP
cold inducible RNA binding protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24223948
NCBI chr19:1,269,332...1,274,880
Ensembl chr19:1,259,384...1,274,880
G
ALDH2
aldehyde dehydrogenase 2 family member
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ANKK1
ankyrin repeat and kinase domain containing 1
IAGP
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr11:113,387,779...113,400,416
Ensembl chr11:113,387,779...113,400,416
G
DRD2
dopamine receptor D2
IAGP
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
FOXO4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chr X:71,095,851...71,103,532
Ensembl chr X:71,095,851...71,103,535
G
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
HECTD4
HECT domain E3 ubiquitin protein ligase 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chr12:112,160,195...112,382,431
Ensembl chr12:112,160,188...112,382,439
G
ANK3
ankyrin 3
IAGP
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490
G
ARHGEF10
Rho guanine nucleotide exchange factor 10
IAGP
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chr 8:1,823,300...1,958,641
Ensembl chr 8:1,823,926...1,958,641
G
RPS6KA1
ribosomal protein S6 kinase A1
IAGP
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chr 1:26,529,761...26,575,025
Ensembl chr 1:26,529,761...26,575,030
G
IGF1
insulin like growth factor 1
ISO
RGD
PMID:23016131
RGD:10402569
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF1R
insulin like growth factor 1 receptor
ISO
RGD
PMID:23016131
RGD:10402569
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
IGF2
insulin like growth factor 2
ISO
RGD
PMID:23016131
RGD:10402569
NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
G
NR3C1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
RGD
PMID:18093169
RGD:408345248
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
HTR2A
5-hydroxytryptamine receptor 2A
IAGP
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chr13:46,831,546...46,898,082
Ensembl chr13:46,831,546...46,897,076
G
AKAP9
A-kinase anchoring protein 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 7:91,940,862...92,110,673
Ensembl chr 7:91,940,840...92,110,673
G
ALAD
aminolevulinate dehydratase
ISO
protein:decreased activity:blood (rat)
RGD
PMID:19022878
RGD:4144202
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
G
AQP9
aquaporin 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19805235
NCBI chr15:58,138,169...58,185,911
Ensembl chr15:58,138,169...58,185,911
G
AS3MT
arsenite methyltransferase
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21447609 PMID:26366667 PMID:35226250
NCBI chr10:102,869,470...102,901,899
Ensembl chr10:102,869,470...102,901,899
G
ATXN7
ataxin 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:63,863,144...64,003,462
Ensembl chr 3:63,863,155...64,003,462
G
CCL20
C-C motif chemokine ligand 20
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
CCL3L3
C-C motif chemokine ligand 3 like 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr17:36,194,869...36,196,758
Ensembl chr17:36,194,869...36,196,758
G
CCL4
C-C motif chemokine ligand 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCRL2
C-C motif chemokine receptor like 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:46,407,259...46,409,523
Ensembl chr 3:46,407,166...46,412,997
G
CD44
CD44 molecule (IN blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
G
CD83
CD83 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 6:14,117,256...14,136,918
Ensembl chr 6:14,117,256...14,140,682
G
CDKN1A
cyclin dependent kinase inhibitor 1A
IEP
protein:increased expression:skin:
RGD
PMID:11860939
RGD:8662429
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
G
CRP
C-reactive protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22521605
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CXCL2
C-X-C motif chemokine ligand 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL3
C-X-C motif chemokine ligand 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 4:74,036,589...74,038,689
Ensembl chr 4:74,036,589...74,038,807
G
ERCC1
ERCC excision repair 1, endonuclease non-catalytic subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12569548
NCBI chr19:45,407,334...45,451,547
Ensembl chr19:45,407,334...45,478,828
G
ERCC3
ERCC excision repair 3, TFIIH core complex helicase subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12569548
NCBI chr 2:127,257,290...127,294,144
Ensembl chr 2:127,257,290...127,294,166
G
ERCC4
ERCC excision repair 4, endonuclease catalytic subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12569548
NCBI chr16:13,920,154...13,952,348
Ensembl chr16:13,920,138...13,952,348
G
GADD45B
growth arrest and DNA damage inducible beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,805
G
GOLGA4
golgin A4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:37,243,271...37,366,879
Ensembl chr 3:37,243,191...37,366,879
G
GSR
glutathione-disulfide reductase
ISO
RGD
PMID:25209654
RGD:10401880
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
HSPA1B
heat shock protein family A (Hsp70) member 1B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
G
ID2
inhibitor of DNA binding 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
G
IER3
immediate early response 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
G
IGF2BP2
insulin like growth factor 2 mRNA binding protein 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:35226250
NCBI chr 3:185,643,130...185,825,042
Ensembl chr 3:185,643,130...185,825,042
G
IL1A
interleukin 1 alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
INPP5A
inositol polyphosphate-5-phosphatase A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25759212
NCBI chr10:132,537,787...132,783,480
Ensembl chr10:132,537,787...132,783,480
G
KCNJ2
potassium inwardly rectifying channel subfamily J member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr17:70,169,532...70,180,044
Ensembl chr17:70,168,673...70,180,044
G
KRT10
keratin 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19953893
NCBI chr17:40,818,117...40,822,614
Ensembl chr17:40,818,117...40,822,614
G
METTL14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:35226250
NCBI chr 4:118,685,392...118,715,430
Ensembl chr 4:118,685,392...118,715,433
G
MINPP1
multiple inositol-polyphosphate phosphatase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr10:87,504,893...87,553,461
Ensembl chr10:87,504,875...87,553,461
G
MIR145
microRNA 145
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29705342
NCBI chr 5:149,430,646...149,430,733
Ensembl chr 5:149,430,646...149,430,733
G
MIR155
microRNA 155
IEP
miRNA:increased expression:serum
RGD
PMID:27913196
RGD:25314296
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MT1A
metallothionein 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19953893
NCBI chr16:56,638,666...56,640,087
Ensembl chr16:56,638,666...56,640,087
G
MTHFR
methylenetetrahydrofolate reductase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24384392
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
N4BP2L2
NEDD4 binding protein 2 like 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr13:32,432,485...32,538,868
Ensembl chr13:32,432,417...32,538,885
G
NDUFB8
NADH:ubiquinone oxidoreductase subunit B8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr10:100,523,729...100,529,923
Ensembl chr10:100,523,668...100,530,000
G
NLRP3
NLR family pyrin domain containing 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:35226250
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
G
NR4A2
nuclear receptor subfamily 4 group A member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:156,324,437...156,332,721
Ensembl chr 2:156,324,437...156,342,348
G
PDE4B
phosphodiesterase 4B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579
G
PELI1
pellino E3 ubiquitin protein ligase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:64,092,652...64,144,420
Ensembl chr 2:64,092,652...64,144,420
G
PFKFB3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr10:6,144,921...6,326,637
Ensembl chr10:6,144,934...6,254,644
G
PIAS1
protein inhibitor of activated STAT 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr15:68,054,315...68,193,847
Ensembl chr15:68,054,309...68,198,603
G
PNP
purine nucleoside phosphorylase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18414634
NCBI chr14:20,469,406...20,477,089
Ensembl chr14:20,461,992...20,477,094
G
PTX3
pentraxin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633
G
RFX3
regulatory factor X3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 9:3,218,297...3,526,001
Ensembl chr 9:3,218,297...3,526,004
G
RGS1
regulator of G protein signaling 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 1:192,575,773...192,580,024
Ensembl chr 1:192,575,763...192,580,024
G
RNF20
ring finger protein 20
IEP
protein:increased expression:urine (human)
RGD
PMID:21136906
RGD:9831407
NCBI chr 9:101,533,853...101,563,344
Ensembl chr 9:101,533,853...101,563,344
G
RUFY3
RUN and FYVE domain containing 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 4:70,703,767...70,808,619
Ensembl chr 4:70,704,204...70,808,619
G
SFPQ
splicing factor proline and glutamine rich
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 1:35,176,380...35,193,145
Ensembl chr 1:35,176,378...35,193,446
G
SKIL
SKI like proto-oncogene
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:170,357,715...170,396,849
Ensembl chr 3:170,357,342...170,396,835
G
SOD2
superoxide dismutase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SOX18
SRY-box transcription factor 18
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr20:64,047,582...64,049,639
Ensembl chr20:64,047,582...64,049,639
G
SRP68
signal recognition particle 68
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr17:76,038,785...76,072,517
Ensembl chr17:76,038,775...76,072,517
G
SSBP1
single stranded DNA binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 7:141,738,321...141,750,488
Ensembl chr 7:141,738,334...141,787,922
G
TAF1D
TATA-box binding protein associated factor, RNA polymerase I subunit D
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr11:93,730,194...93,741,495
Ensembl chr11:93,729,948...93,784,391
G
TNF
tumor necrosis factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP6
TNF alpha induced protein 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046
G
TNIK
TRAF2 and NCK interacting kinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:171,058,414...171,460,408
Ensembl chr 3:171,058,414...171,460,408
G
TP53
tumor protein p53
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18621066 PMID:19203779
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
TRA2A
transformer 2 alpha homolog
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 7:23,504,780...23,531,981
Ensembl chr 7:23,504,780...23,532,041
G
TRAPPC10
trafficking protein particle complex subunit 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr21:44,012,309...44,106,552
Ensembl chr21:44,012,309...44,106,552
G
UBE2E1
ubiquitin conjugating enzyme E2 E1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:23,805,955...23,891,640
Ensembl chr 3:23,805,955...23,891,640
G
USO1
USO1 vesicle transport factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 4:75,724,577...75,814,286
Ensembl chr 4:75,724,577...75,814,286
G
USP13
ubiquitin specific peptidase 13
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr 3:179,653,040...179,789,401
Ensembl chr 3:179,653,032...179,804,366
G
ZFAND6
zinc finger AN1-type containing 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr15:80,058,951...80,138,393
Ensembl chr15:80,059,568...80,140,292
G
ZNF267
zinc finger protein 267
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr16:31,873,807...31,917,357
Ensembl chr16:31,873,807...31,917,357
G
ZNF331
zinc finger protein 331
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16835338
NCBI chr19:53,503,235...53,580,269
Ensembl chr19:53,519,527...53,580,269
G
ACHE
acetylcholinesterase (Yt blood group)
treatment
ISO
RGD
PMID:27491636
RGD:152995409
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
ADA
adenosine deaminase
treatment
ISO
RGD
PMID:27491636
RGD:152995409
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
G
CPA1
carboxypeptidase A1
ISO
protein:increased activity:small intestine (rat)
RGD
PMID:15865404
RGD:1578424
NCBI chr 7:130,380,494...130,388,108
Ensembl chr 7:130,380,339...130,388,114
G
ENPP2
ectonucleotide pyrophosphatase/phosphodiesterase 2
ISO
protein:increased activity:plasma:
RGD
PMID:24361405
RGD:9685430
NCBI chr 8:119,557,086...119,673,390
Ensembl chr 8:119,557,086...119,673,453
G
GPX1
glutathione peroxidase 1
treatment
ISO
RGD
PMID:24954678
RGD:11352769
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GPX4
glutathione peroxidase 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643113
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
G
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24200859
RGD:10401881
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
HTT
huntingtin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19845833
NCBI chr 4:3,074,681...3,243,960
Ensembl chr 4:3,041,363...3,243,957
G
IL6
interleukin 6
ISO
in males;protein:increased expression, increased activity:plasma (rat)
RGD
PMID:19462680
RGD:11060270
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
MT3
metallothionein 3
ISO
RGD
PMID:20371971
RGD:6480494
NCBI chr16:56,589,528...56,591,085
Ensembl chr16:56,589,074...56,591,088
G
NUDT1
nudix hydrolase 1
ISO
RGD
PMID:11817101
RGD:633232
NCBI chr 7:2,242,226...2,251,145
Ensembl chr 7:2,242,226...2,251,146
G
SELENOP
selenoprotein P
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20643113
NCBI chr 5:42,799,880...42,811,892
Ensembl chr 5:42,799,880...42,887,392
G
CHRNA3
cholinergic receptor nicotinic alpha 3 subunit
ISO
RGD
PMID:24704181
RGD:151347543
NCBI chr15:78,593,052...78,620,996
Ensembl chr15:78,593,052...78,621,295
G
HMOX1
heme oxygenase 1
ISO
RGD
PMID:20422170 PMID:19520142
RGD:4145288 , RGD:4145306
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
MBP
myelin basic protein
ISO
protein:decreased expression:brain:
RGD
PMID:23146304
RGD:7327205
NCBI chr18:76,978,833...77,133,708
Ensembl chr18:76,978,827...77,133,683
G
NOS1
nitric oxide synthase 1
ISO
RGD
PMID:14761684
RGD:13825130
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
G
XDH
xanthine dehydrogenase
ISO
RGD
PMID:17433579 PMID:8248931
RGD:13209022 , RGD:13210748
NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
G
FADD
Fas associated via death domain
treatment
ISO
RGD
PMID:25687490
RGD:11341810
NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
G
GFER
growth factor, augmenter of liver regeneration
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:15968720
NCBI chr16:1,984,193...1,987,749
Ensembl chr16:1,984,193...1,987,749
G
GPX1
glutathione peroxidase 1
ISO
RGD
PMID:18306454
RGD:2312624
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GPX2
glutathione peroxidase 2
treatment
ISO
RGD
PMID:31018559
RGD:401827907
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
GPX3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:31018559 PMID:18306454
RGD:401827907 , RGD:2312624
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
G
HMOX1
heme oxygenase 1
ISO
RGD
PMID:24748974
RGD:10755718
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
LTF
lactotransferrin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16141546
NCBI chr 3:46,435,645...46,485,234
Ensembl chr 3:46,435,645...46,485,234
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
RGD
PMID:23684718
RGD:11035220
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
UCP2
uncoupling protein 2
ISO
protein:increased expression:liver
RGD
PMID:19104935
RGD:7204431
NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,061...73,982,843
G
AASS
aminoadipate-semialdehyde synthase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:122,073,549...122,144,249
Ensembl chr 7:122,064,583...122,144,308
G
ABCB1
ATP binding cassette subfamily B member 1
severity susceptibility
ISO IAGP EXP
DNA:SNP::2677G>T/A(rs2032582)(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20623750 PMID:26134275 PMID:26134275 PMID:27296832
RGD:11041130 , RGD:14700895
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ABCB11
ATP binding cassette subfamily B member 11
severity
IAGP
DNA:SNP: :rs2287616(human)
RGD
PMID:27293027
RGD:14402413
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
ABCC1
ATP binding cassette subfamily C member 1 (ABCC1 blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18466103
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
G
ABCC2
ATP binding cassette subfamily C member 2
susceptibility
EXP IAGP IEP
CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-24C>T(human)
CTD RGD
PMID:18381794 PMID:18466103 PMID:17241877 PMID:25196354
RGD:14700814 , RGD:14700812
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABI1
abl interactor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:26,746,596...26,860,958
Ensembl chr10:26,746,593...26,861,087
G
ACE
angiotensin I converting enzyme
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:25143335
RGD:25671447
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ACOX3
acyl-CoA oxidase 3, pristanoyl
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:8,355,305...8,440,723
Ensembl chr 4:8,366,282...8,440,723
G
ACSL1
acyl-CoA synthetase long chain family member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818
G
ACTB
actin beta
ISO EXP
mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25231249 PMID:22563491
RGD:9587759
NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
G
ACTN4
actinin alpha 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:38,647,649...38,731,589
Ensembl chr19:38,647,649...38,731,589
G
ACTR3
actin related protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:113,889,934...113,962,596
Ensembl chr 2:113,890,063...113,962,596
G
ADA
adenosine deaminase
ISO
protein:increased expression:liver
RGD
PMID:21161045
RGD:5128859
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
G
ADAM8
ADAM metallopeptidase domain 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24646716
NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:20709802
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADIPOR2
adiponectin receptor 2
severity
ISO
associated with obesity, LPS;mRNA:decreased expression:liver (rat)
RGD
PMID:23838384
RGD:8695926
NCBI chr12:1,691,070...1,788,674
Ensembl chr12:1,688,574...1,788,674
G
ADORA2B
adenosine A2b receptor
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:35292334
NCBI chr17:15,850,362...15,975,746
Ensembl chr17:15,945,130...15,975,746
G
AGT
angiotensinogen
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29499335
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AHR
aryl hydrocarbon receptor
EXP ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:decreased expression:liver (rat)
CTD RGD
PMID:21890736 PMID:34848246 PMID:28959666
RGD:401794432
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
AIFM1
apoptosis inducing factor mitochondria associated 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25743375
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
G
AK4
adenylate kinase 4
ISO
protein:increased expression:liver (rat)
RGD
PMID:16538043
RGD:2301096
NCBI chr 1:65,147,552...65,232,145
Ensembl chr 1:65,147,549...65,232,145
G
AKR1A1
aldo-keto reductase family 1 member A1
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32805337 PMID:29763686
RGD:27226688
NCBI chr 1:45,550,826...45,570,049
Ensembl chr 1:45,550,543...45,570,049
G
ALB
albumin
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18779383 PMID:22310181 PMID:27567545
RGD:14694844
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ALDH1L2
aldehyde dehydrogenase 1 family member L2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:105,019,790...105,084,458
Ensembl chr12:105,019,784...105,107,643
G
ALDH2
aldehyde dehydrogenase 2 family member
severity susceptibility
ISO
protein:increased expression:liver DNA:deletion:exon 3 (mouse)
RGD
PMID:21138988 PMID:30121625 PMID:24492981
RGD:7241599 , RGD:15036810 , RGD:14975148
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ALDH9A1
aldehyde dehydrogenase 9 family member A1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:165,662,216...165,698,562
Ensembl chr 1:165,662,216...165,698,562
G
ALDOB
aldolase, fructose-bisphosphate B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16115720
NCBI chr 9:101,420,560...101,435,774
Ensembl chr 9:101,420,560...101,449,664
G
AMBP
alpha-1-microglobulin/bikunin precursor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18779383
NCBI chr 9:114,060,127...114,078,300
Ensembl chr 9:114,060,127...114,078,328
G
ANXA2
annexin A2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883
G
ANXA6
annexin A6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:151,100,706...151,157,779
Ensembl chr 5:151,100,706...151,157,815
G
APOA1
apolipoprotein A1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr11:116,835,751...116,837,622
Ensembl chr11:116,835,751...116,837,622
G
APOE
apolipoprotein E
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
APOH
apolipoprotein H
ISO EXP
mRNA:increased expression:plasma: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16099942 PMID:23288050
RGD:10054107
NCBI chr17:66,212,033...66,229,415
Ensembl chr17:66,212,033...66,256,525
G
ARG1
arginase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22872058
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
G
ARNT
aryl hydrocarbon receptor nuclear translocator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20935161
NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
G
ATG5
autophagy related 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22491424
NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,325,791
G
ATOH8
atonal bHLH transcription factor 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:85,753,991...85,791,383
Ensembl chr 2:85,751,344...85,791,383
G
ATP6V1D
ATPase H+ transporting V1 subunit D
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr14:67,337,872...67,359,804
Ensembl chr14:67,294,371...67,360,265
G
AVP
arginine vasopressin
IAGP
DNA:SNP:intron: (rs2282018)
RGD
PMID:28462386
RGD:408364979
NCBI chr20:3,082,556...3,084,724
Ensembl chr20:3,082,556...3,084,724
G
BAD
BCL2 associated agonist of cell death
treatment
ISO
RGD
PMID:25447754
RGD:10053709
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
G
BAX
BCL2 associated X, apoptosis regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17906064
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BDH1
3-hydroxybutyrate dehydrogenase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323
G
BDKRB2
bradykinin receptor B2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
G
BLVRB
biliverdin reductase B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,764
G
BMAL1
basic helix-loop-helix ARNT like 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:36602574
NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,652...13,387,266
G
BPNT1
3'(2'), 5'-bisphosphate nucleotidase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:220,057,482...220,089,788
Ensembl chr 1:220,057,482...220,090,462
G
BRD4
bromodomain containing 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:15,235,519...15,332,539
Ensembl chr19:15,235,519...15,332,545
G
BTD
biotinidase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15469856
NCBI chr 3:15,601,361...15,722,516
Ensembl chr 3:15,601,341...15,722,311
G
C3
complement C3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CA3
carbonic anhydrase 3
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513 PMID:25231249
NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040
G
CABP1
calcium binding protein 1
ISO
protein:increased expression:liver
RGD
PMID:21138988
RGD:7241599
NCBI chr12:120,640,626...120,680,866
Ensembl chr12:120,640,626...120,667,324
G
CADPS2
calcium dependent secretion activator 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 7:122,318,411...122,886,460
Ensembl chr 7:122,318,411...122,886,759
G
CANX
calnexin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:179,678,656...179,731,641
Ensembl chr 5:179,678,628...179,731,641
G
CAP1
cyclase associated actin cytoskeleton regulatory protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:40,040,240...40,072,648
Ensembl chr 1:40,040,233...40,072,649
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:25447754
RGD:10053709
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CAST
calpastatin
ISO
RGD
PMID:16871587
RGD:5683869
NCBI chr 5:95,961,429...96,774,683
Ensembl chr 5:96,247,756...96,779,595 Ensembl chr 5:96,247,756...96,779,595
G
CAT
catalase
EXP ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver
CTD RGD
PMID:20623750 PMID:25231249 PMID:21138988
RGD:7241599
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCDC80
coiled-coil domain containing 80
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:112,596,797...112,641,143
Ensembl chr 3:112,596,797...112,649,530
G
CCL2
C-C motif chemokine ligand 2
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20623750 PMID:21813474 PMID:30663942
RGD:14995466 , RGD:14995458
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCR2
C-C motif chemokine receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR5
C-C motif chemokine receptor 5
susceptibility
ISO
acetaminophen
RGD
PMID:24770590
RGD:14401733
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CCT3
chaperonin containing TCP1 subunit 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:156,308,968...156,338,292
Ensembl chr 1:156,308,968...156,367,873
G
CCT5
chaperonin containing TCP1 subunit 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:10,249,921...10,266,412
Ensembl chr 5:10,249,929...10,266,389
G
CDC25B
cell division cycle 25B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr20:3,786,951...3,806,115
Ensembl chr20:3,786,772...3,806,121
G
CDS1
CDP-diacylglycerol synthase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 4:84,583,127...84,651,334
Ensembl chr 4:84,583,127...84,651,334
G
CELA1
chymotrypsin like elastase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr12:51,328,442...51,346,679
Ensembl chr12:51,328,442...51,346,679
G
CFAP20
cilia and flagella associated protein 20
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr16:58,113,592...58,129,381
Ensembl chr16:58,113,592...58,129,381
G
CFH
complement factor H
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:196,652,043...196,747,504
Ensembl chr 1:196,651,754...196,752,476
G
CHRM3
cholinergic receptor muscarinic 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20197374
NCBI chr 1:239,386,568...239,915,450
Ensembl chr 1:239,386,565...239,915,452
G
CKB
creatine kinase B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
G
CLU
clusterin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
COL14A1
collagen type XIV alpha 1 chain
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 8:120,124,454...120,373,573
Ensembl chr 8:120,059,780...120,373,573
G
COL3A1
collagen type III alpha 1 chain
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16679477
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
G
COMT
catechol-O-methyltransferase
ISO
protein:decreased expression:liver
RGD
PMID:21138988
RGD:7241599
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
G
COQ9
coenzyme Q9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr16:57,447,479...57,461,270
Ensembl chr16:57,447,425...57,461,270
G
CP
ceruloplasmin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
G
CPB2
carboxypeptidase B2
ISO
mRNA,protein:increased expression,increased activity:liver,plasma
RGD
PMID:19386599
RGD:7243112
NCBI chr13:46,053,186...46,105,033
Ensembl chr13:46,053,186...46,105,033
G
CPS1
carbamoyl-phosphate synthase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107
G
CPT1A
carnitine palmitoyltransferase 1A
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
G
CRP
C-reactive protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CSF3
colony stimulating factor 3
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:20005281 PMID:33882750
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
G
CTNNB1
catenin beta 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:19679878
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
CTSE
cathepsin E
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:206,009,264...206,023,895
Ensembl chr 1:206,008,535...206,023,909
G
CXCL1
C-X-C motif chemokine ligand 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16118408
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL10
C-X-C motif chemokine ligand 10
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:11739529
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL14
C-X-C motif chemokine ligand 14
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:38614205
NCBI chr 5:135,570,679...135,578,991
Ensembl chr 5:135,570,679...135,579,279
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33814510
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33814510
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP27B1
cytochrome P450 family 27 subfamily B member 1
ISO
mRNA, protein:decreased expression:kidney (mouse)
RGD
PMID:26476181
RGD:25671412
NCBI chr12:57,762,334...57,767,078
Ensembl chr12:57,762,334...57,768,986
G
CYP2A6
cytochrome P450 family 2 subfamily A member 6
EXP ISO
CTD Direct Evidence: marker/mechanism CTD Direct Evidence: therapeutic
CTD
PMID:21741958 PMID:23628428
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
G
CYP2B6
cytochrome P450 family 2 subfamily B member 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043 PMID:33814510
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
G
CYP2C18
cytochrome P450 family 2 subfamily C member 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12963435 PMID:28762043
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
CYP2C9
cytochrome P450 family 2 subfamily C member 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:14971821 PMID:21741958 PMID:28762043 PMID:33814510
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)
IAGP
DNA:hypermethylation:promoter
RGD
PMID:27490558
RGD:14700879
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
treatment
EXP ISO IAGP IMP
CTD Direct Evidence: marker/mechanism DNA:hypermethylation:promoter associated with Endotoxemia
CTD RGD
PMID:12668988 PMID:16770646 PMID:21741958 PMID:28762043 PMID:27960551 PMID:27490558 PMID:27324775 PMID:29404441 PMID:25681370 More...
RGD:14700901 , RGD:14700879 , RGD:14700878 , RGD:14700873 , RGD:14700872
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25448281
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
G
DBT
dihydrolipoamide branched chain transacylase E2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:100,186,919...100,249,834
Ensembl chr 1:100,186,919...100,249,834
G
DDB1
damage specific DNA binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:61,299,451...61,333,105
Ensembl chr11:61,299,451...61,342,596
G
DGAT2
diacylglycerol O-acyltransferase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
G
DHFR
dihydrofolate reductase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19648163
NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
G
DHRS7
dehydrogenase/reductase 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr14:60,144,119...60,169,889
Ensembl chr14:60,144,119...60,169,856
G
DLAT
dihydrolipoamide S-acetyltransferase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:112,025,408...112,064,404
Ensembl chr11:112,025,033...112,064,404
G
DNAJB9
DnaJ heat shock protein family (Hsp40) member B9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850
G
DNAJC12
DnaJ heat shock protein family (Hsp40) member C12
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr10:67,796,669...67,838,188
Ensembl chr10:67,796,669...67,838,188
G
DSC2
desmocollin 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,545...31,102,600
G
E2F1
E2F transcription factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
G
ECHDC1
ethylmalonyl-CoA decarboxylase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 6:127,288,712...127,343,609
Ensembl chr 6:127,288,712...127,343,609
G
ECHS1
enoyl-CoA hydratase, short chain 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:133,362,485...133,373,354
Ensembl chr10:133,362,485...133,373,354
G
EDEM1
ER degradation enhancing alpha-mannosidase like protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:5,187,707...5,219,958
Ensembl chr 3:5,187,646...5,219,958
G
EIF2AK1
eukaryotic translation initiation factor 2 alpha kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25411909
NCBI chr 7:6,022,247...6,059,175
Ensembl chr 7:6,022,247...6,059,175
G
EIF4EBP2
eukaryotic translation initiation factor 4E binding protein 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:70,404,145...70,428,618
Ensembl chr10:70,404,145...70,428,618
G
ENDOG
endonuclease G
ISO
protein:decreased expression:mitochondrion:
RGD
PMID:22509279
RGD:9685364
NCBI chr 9:128,818,500...128,822,676
Ensembl chr 9:128,818,500...128,822,676
G
ENG
endoglin
ISO
protein:increased expression:liver (rat)
RGD
PMID:21146604
RGD:7257529
NCBI chr 9:127,815,016...127,854,658
Ensembl chr 9:127,811,130...127,854,773
G
ENO1
enolase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942 PMID:25231249
NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
G
ENPP2
ectonucleotide pyrophosphatase/phosphodiesterase 2
ISO
protein:increased activity:serum:
RGD
PMID:17850827
RGD:9685426
NCBI chr 8:119,557,086...119,673,390
Ensembl chr 8:119,557,086...119,673,453
G
EPHX1
epoxide hydrolase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
ERLEC1
endoplasmic reticulum lectin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 2:53,787,044...53,818,796
Ensembl chr 2:53,787,009...53,833,038
G
ERN1
endoplasmic reticulum to nucleus signaling 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30538632
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
G
F13A1
coagulation factor XIII A chain
ISO
RGD
PMID:22019897
RGD:11041813
NCBI chr 6:6,144,084...6,320,662
Ensembl chr 6:6,144,084...6,321,013
G
F2RL3
F2R like thrombin or trypsin receptor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974703
NCBI chr19:16,888,999...16,892,606
Ensembl chr19:16,888,999...16,892,606
G
F3
coagulation factor III, tissue factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22407844
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
G
FADD
Fas associated via death domain
treatment
ISO
RGD
PMID:26062544 PMID:25447754
RGD:11341803 , RGD:10053709
NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
G
FADS1
fatty acid desaturase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:61,799,627...61,817,003
Ensembl chr11:61,799,627...61,829,318
G
FADS2
fatty acid desaturase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:61,816,203...61,867,354
Ensembl chr11:61,792,980...61,867,354
G
FAS
Fas cell surface death receptor
ISO
protein:increased expression:liver (rat)
RGD
PMID:16831245
RGD:8662853
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FASN
fatty acid synthase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
G
FCMR
Fc mu receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:206,903,317...206,923,196
Ensembl chr 1:206,903,317...206,923,247
G
FGA
fibrinogen alpha chain
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974703
NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742
G
FGF21
fibroblast growth factor 21
severity
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:29883717
RGD:15045603
NCBI chr19:48,755,524...48,758,330
Ensembl chr19:48,755,524...48,758,333
G
FLT1
fms related receptor tyrosine kinase 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:21135413
NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
G
FMO3
flavin containing dimethylaniline monoxygenase 3
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:24973094
NCBI chr 1:171,090,905...171,117,819
Ensembl chr 1:171,090,901...171,117,819
G
FTL
ferritin light chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,967,896
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
ISO
mRNA:decreased expression:liver (mouse)
RGD
PMID:28189721
RGD:14695531
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
G
G6PD
glucose-6-phosphate dehydrogenase
treatment
ISO
RGD
PMID:21864513
RGD:10449168
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GADD45A
growth arrest and DNA damage inducible alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GANAB
glucosidase II alpha subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:62,624,829...62,646,613
Ensembl chr11:62,624,826...62,646,726
G
GC
GC vitamin D binding protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
G
GCLC
glutamate-cysteine ligase catalytic subunit
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19481141 PMID:17573345
RGD:10402383
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GDA
guanine deaminase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:72,114,608...72,259,869
Ensembl chr 9:72,114,595...72,257,193
G
GDI1
GDP dissociation inhibitor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:154,437,154...154,443,467
Ensembl chr X:154,436,913...154,443,467
G
GFER
growth factor, augmenter of liver regeneration
treatment
IDA ISO
RGD
PMID:22033404 PMID:15968720
RGD:9685722 , RGD:9685727
NCBI chr16:1,984,193...1,987,749
Ensembl chr16:1,984,193...1,987,749
G
GGH
gamma-glutamyl hydrolase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21219404
NCBI chr 8:63,015,079...63,038,806
Ensembl chr 8:63,014,881...63,039,407
G
GGT1
gamma-glutamyltransferase 1
ISO
RGD
PMID:10934156
RGD:14701049
NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
G
GHRL
ghrelin and obestatin prepropeptide
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:34151639
NCBI chr 3:10,285,666...10,292,947
Ensembl chr 3:10,285,666...10,292,947
G
GLUD1
glutamate dehydrogenase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33483742
NCBI chr10:87,050,202...87,094,843
Ensembl chr10:87,050,202...87,094,843
G
GOT1
glutamic-oxaloacetic transaminase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
G
GPD1
glycerol-3-phosphate dehydrogenase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:50,104,008...50,111,313
Ensembl chr12:50,103,982...50,111,313
G
GPT
glutamic--pyruvic transaminase
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression, activity:serum:
CTD RGD
PMID:145039 PMID:19481104 PMID:19085960 PMID:19085960 PMID:27293452 PMID:21772750 PMID:28487901 More...
RGD:14975249 , RGD:14975249 , RGD:14975168 , RGD:14975166 , RGD:14975162
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GPT2
glutamic--pyruvic transaminase 2
ISO
protein:increased expression, activity:serum:
RGD
PMID:19085960 PMID:19085960
RGD:14975249 , RGD:14975249
NCBI chr16:46,884,362...46,931,289
Ensembl chr16:46,884,362...46,931,289
G
GRK4
G protein-coupled receptor kinase 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:2,963,571...3,040,760
Ensembl chr 4:2,963,571...3,040,760
G
GSN
gelsolin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
G
GSR
glutathione-disulfide reductase
treatment
ISO EXP
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25226513 PMID:28069987 PMID:23554813 PMID:24154663
RGD:7257532 , RGD:10401878
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GSTA1
glutathione S-transferase alpha 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28412881
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
G
GSTA4
glutathione S-transferase alpha 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:52,977,953...52,995,284
Ensembl chr 6:52,977,948...52,995,304
G
GSTM1
glutathione S-transferase mu 1
no_association
EXP IAGP ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver
CTD RGD
PMID:17465707 PMID:18666253 PMID:25501156 PMID:24465778 PMID:24903797 PMID:29523098 PMID:21138988 More...
RGD:14700970 , RGD:14700959 , RGD:14700941 , RGD:14700937 , RGD:7241599
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTM2
glutathione S-transferase mu 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
G
GSTM3
glutathione S-transferase mu 3
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:25743375
NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
G
GSTM4
glutathione S-transferase mu 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:109,656,099...109,667,727
Ensembl chr 1:109,656,099...109,665,496
G
GSTO1
glutathione S-transferase omega 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:104,254,173...104,267,455
Ensembl chr10:104,235,356...104,267,459
G
GSTP1
glutathione S-transferase pi 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750 PMID:25226513
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
GSTT1
glutathione S-transferase theta 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18397238 PMID:18666253 PMID:25226513
G
GULOP
gulonolactone (L-) oxidase, pseudogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 8:27,577,611...27,589,073
Ensembl chr 8:27,560,274...27,589,073
G
H19
H19 imprinted maternally expressed transcript
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr11:1,995,176...2,001,266
Ensembl chr11:1,995,165...2,004,552
G
H2AX
H2A.X variant histone
treatment
ISO
RGD
PMID:23265463
RGD:8693741
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
G
HACL1
2-hydroxyacyl-CoA lyase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 3:15,560,699...15,601,569
Ensembl chr 3:15,560,699...15,601,852
G
HADHA
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:26,190,635...26,244,632
Ensembl chr 2:26,190,635...26,244,672
G
HAMP
hepcidin antimicrobial peptide
ISO
mRNA:increased expression:hepatocyte
RGD
PMID:24373749
RGD:11041724
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
G
HAO2
hydroxyacid oxidase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:119,368,785...119,394,130
Ensembl chr 1:119,368,779...119,394,130
G
HAVCR1
hepatitis A virus cellular receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
G
HBA1
hemoglobin subunit alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr16:176,680...177,522
Ensembl chr16:176,680...177,522
G
HCP5
HLA complex P5
IAGP
ClinVar Annotator: match by term: Drug-induced liver injury due to flucloxacillin
ClinVar
PMID:11888582 PMID:11943262 PMID:12462283 PMID:15024131 PMID:15247624 PMID:15247625 PMID:18256392 PMID:19483685 More...
NCBI chr 6:31,463,180...31,465,809
Ensembl chr 6:31,463,144...31,494,470
G
HLA-A
major histocompatibility complex, class I, A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570397 PMID:28043905
NCBI chr 6:29,942,532...29,945,870
Ensembl chr 6:29,941,260...29,949,572
G
HLA-B
major histocompatibility complex, class I, B
IAGP EXP
ClinVar Annotator: match by term: Drug-induced liver injury due to flucloxacillin CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:11888582 PMID:11943262 PMID:12462283 PMID:15024131 PMID:15247624 PMID:15247625 PMID:18256392 PMID:19483685 More...
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
IAGP
DNA:polymorphism: :HLA-DQA1*0102(human) associated with tuberculosis;DNA:polymorphism: :HLA-DQA1*0102(human)
RGD
PMID:20639878 PMID:12359646
RGD:14398844 , RGD:14401573
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :HLA-DQB1*05(human) DNA:polymorphism, haplotype
CTD RGD
PMID:21570397 PMID:25250564 PMID:26959717
RGD:36174016 , RGD:11573514
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570397
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HMGB1
high mobility group box 1
treatment
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19783637 PMID:29091898
RGD:15090820
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HMOX1
heme oxygenase 1
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898
RGD:10762620 , RGD:15090820
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HPD
4-hydroxyphenylpyruvate dioxygenase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942 PMID:22872058
NCBI chr12:121,839,527...121,888,611
Ensembl chr12:121,839,527...121,863,596
G
HPRT1
hypoxanthine phosphoribosyltransferase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:134,460,165...134,500,668
Ensembl chr X:134,460,165...134,520,513
G
HPX
hemopexin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr11:6,431,049...6,440,987
Ensembl chr11:6,431,049...6,442,617
G
HRH2
histamine receptor H2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22926047
NCBI chr 5:175,658,071...175,710,756
Ensembl chr 5:175,658,030...175,710,756
G
HSPA5
heat shock protein family A (Hsp70) member 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein:altered localization:liver (rat)
RGD
PMID:12376827
RGD:10059389
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:29091898
RGD:15090820
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
severity
ISO
RGD
PMID:31121248
RGD:14985250
NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
G
IDO2
indoleamine 2,3-dioxygenase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32289347
NCBI chr 8:39,934,651...40,016,392
Ensembl chr 8:39,934,614...40,016,392
G
IFNA2
interferon alpha 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:1670585
NCBI chr 9:21,384,255...21,385,398
Ensembl chr 9:21,384,255...21,385,398
G
IFNG
interferon gamma
EXP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12153990 PMID:21245496 PMID:30013034
RGD:14975100
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IGF1
insulin like growth factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23639586 PMID:25226513
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IL11
interleukin 11
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:11421492
NCBI chr19:55,364,382...55,370,463
Ensembl chr19:55,364,382...55,370,463
G
IL12B
interleukin 12B
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
G
IL17A
interleukin 17A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19633216 PMID:24949944
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19164858
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
G
IL1A
interleukin 1 alpha
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:8218930
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
treatment
ISO EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:19164858 PMID:28138970 PMID:23102243 PMID:29091898 PMID:31342809 PMID:31077717 PMID:29278859 More...
RGD:7204421 , RGD:15090820 , RGD:15036799 , RGD:14975281 , RGD:13793380
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1R2
interleukin 1 receptor type 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 2:101,991,960...102,028,544
Ensembl chr 2:101,991,960...102,028,544
G
IL22
interleukin 22
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:15122762 PMID:16212920 PMID:23375450
NCBI chr12:68,248,242...68,253,604
Ensembl chr12:68,248,242...68,253,604
G
IL4
interleukin 4
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21094227 PMID:21735453 PMID:22107450
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL6
interleukin 6
treatment
EXP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:7532385 PMID:15763341 PMID:29091898
RGD:15090820
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IMMT
inner membrane mitochondrial protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 2:86,143,936...86,195,462
Ensembl chr 2:86,143,932...86,195,472
G
IRAK1
interleukin 1 receptor associated kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
G
ITPR1
inositol 1,4,5-trisphosphate receptor type 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
G
JUND
JunD proto-oncogene, AP-1 transcription factor subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622
G
KEAP1
kelch like ECH associated protein 1
ISO
RGD
PMID:18417483
RGD:6893370
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
G
KITLG
KIT ligand
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12594235
NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851
G
KNG1
kininogen 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20362651 PMID:30685357
NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410
G
KRT18
keratin 18
ISO EXP
mRNA, protein:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19783637 PMID:33483742 PMID:38521541 PMID:17340120
RGD:18337498
NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906
G
KRT8
keratin 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:52,897,191...52,949,860
Ensembl chr12:52,897,187...52,949,954
G
LAP3
leucine aminopeptidase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:17,577,198...17,607,970
Ensembl chr 4:17,577,198...17,607,972
G
LBP
lipopolysaccharide binding protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,013
G
LCAT
lecithin-cholesterol acyltransferase
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr16:67,939,750...67,944,120
Ensembl chr16:67,939,750...67,944,131
G
LCN2
lipocalin 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20362651 PMID:20623750
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
G
LDLR
low density lipoprotein receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:36108984
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LGALS3
galectin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22461450
NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
G
LIPC
lipase C, hepatic type
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844
G
LPL
lipoprotein lipase
treatment
ISO
RGD
PMID:27071702
RGD:13794380
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
G
LRAT
lecithin retinol acyltransferase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 4:154,740,838...154,753,120
Ensembl chr 4:154,626,945...154,753,120
G
LTB4R
leukotriene B4 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28487374
NCBI chr14:24,311,502...24,318,036
Ensembl chr14:24,311,450...24,318,036
G
LTF
lactotransferrin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16141546
NCBI chr 3:46,435,645...46,485,234
Ensembl chr 3:46,435,645...46,485,234
G
MALAT1
metastasis associated lung adenocarcinoma transcript 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr11:65,497,738...65,506,516
Ensembl chr11:65,497,606...65,508,073
G
MAP1LC3B
microtubule associated protein 1 light chain 3 beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18700144
NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
G
MAT1A
methionine adenosyltransferase 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:80,271,820...80,289,658
Ensembl chr10:80,271,820...80,289,658
G
MCCC1
methylcrotonyl-CoA carboxylase subunit 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:183,015,218...183,116,196
Ensembl chr 3:183,015,218...183,116,075
G
MDH1
malate dehydrogenase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 2:63,588,963...63,607,197
Ensembl chr 2:63,588,609...63,607,197
G
ME1
malic enzyme 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
MED1
mediator complex subunit 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16109766
NCBI chr17:39,404,285...39,451,263
Ensembl chr17:39,404,285...39,451,272
G
MIR1-1
microRNA 1-1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30125006
NCBI chr20:62,554,306...62,554,376
Ensembl chr20:62,554,306...62,554,376
G
MIR100
microRNA 100
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:122,152,229...122,152,308
Ensembl chr11:122,152,229...122,152,308
G
MIR103A1
microRNA 103a-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 5:168,560,896...168,560,973
Ensembl chr 5:168,560,896...168,560,973
G
MIR106B
microRNA 106b
IEP IDA
miRNA:decreased expression:liver (rat) DNA:hypermethylation:promoter
RGD
PMID:29554950 PMID:29554950
RGD:15042854 , RGD:15042854
NCBI chr 7:100,093,993...100,094,074
Ensembl chr 7:100,093,993...100,094,074
G
MIR107
microRNA 107
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr10:89,592,747...89,592,827
Ensembl chr10:89,592,747...89,592,827
G
MIR10A
microRNA 10a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr17:48,579,838...48,579,947
Ensembl chr17:48,579,838...48,579,947
G
MIR10B
microRNA 10b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 2:176,150,303...176,150,412
Ensembl chr 2:176,150,303...176,150,412
G
MIR122
microRNA 122
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22045675 PMID:22363424 PMID:25359176 PMID:25527335 PMID:26489516 PMID:28545106 PMID:28844483 PMID:33483742 More...
NCBI chr18:58,451,074...58,451,158
Ensembl chr18:58,451,074...58,451,158
G
MIR1246
microRNA 1246
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 2:176,600,980...176,601,052
Ensembl chr 2:176,600,980...176,601,052
G
MIR1247
microRNA 1247
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr14:101,560,287...101,560,422
Ensembl chr14:101,560,287...101,560,422
G
MIR1249
microRNA 1249
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr22:45,200,954...45,201,019
Ensembl chr22:45,200,954...45,201,019
G
MIR125B1
microRNA 125b-1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:122,099,757...122,099,844
Ensembl chr11:122,099,757...122,099,844
G
MIR125B2
microRNA 125b-2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr21:16,590,237...16,590,325
Ensembl chr21:16,590,237...16,590,325
G
MIR1260A
microRNA 1260a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr14:77,266,218...77,266,290
Ensembl chr14:77,266,218...77,266,290
G
MIR1260B
microRNA 1260b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:96,341,438...96,341,526
Ensembl chr11:96,341,438...96,341,526
G
MIR1273H
microRNA 1273h
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:24,203,116...24,203,231
Ensembl chr16:24,203,116...24,203,231
G
MIR1285-1
microRNA 1285-1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:92,204,015...92,204,098
Ensembl chr 7:92,204,015...92,204,098
G
MIR1290
microRNA 1290
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 1:18,897,071...18,897,148
Ensembl chr 1:18,897,071...18,897,148
G
MIR1291
microRNA 1291
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr12:48,654,444...48,654,530
Ensembl chr12:48,654,444...48,654,530
G
MIR1303
microRNA 1303
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:154,685,776...154,685,861
Ensembl chr 5:154,685,776...154,685,861
G
MIR1304
microRNA 1304
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:93,733,674...93,733,764
Ensembl chr11:93,733,674...93,733,764
G
MIR1306
microRNA 1306
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr22:20,086,058...20,086,142
Ensembl chr22:20,086,058...20,086,142
G
MIR1307
microRNA 1307
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:103,394,253...103,394,401
Ensembl chr10:103,394,253...103,394,401
G
MIR130A
microRNA 130a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr11:57,641,198...57,641,286
Ensembl chr11:57,641,198...57,641,286
G
MIR130B
microRNA 130b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr22:21,653,304...21,653,385
Ensembl chr22:21,653,304...21,653,385
G
MIR132
microRNA 132
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr17:2,049,908...2,050,008
Ensembl chr17:2,049,908...2,050,008
G
MIR1343
microRNA 1343
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:34,941,837...34,941,920
Ensembl chr11:34,941,837...34,941,920
G
MIR141
microRNA 141
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:28545106
NCBI chr12:6,964,097...6,964,191
Ensembl chr12:6,964,097...6,964,191
G
MIR142
microRNA 142
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:58,331,232...58,331,318
Ensembl chr17:58,331,232...58,331,318
G
MIR143
microRNA 143
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30125006
NCBI chr 5:149,428,918...149,429,023
Ensembl chr 5:149,428,918...149,429,023
G
MIR1468
microRNA 1468
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:63,786,002...63,786,087
Ensembl chr X:63,786,002...63,786,087
G
MIR148A
microRNA 148a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr 7:25,949,919...25,949,986
Ensembl chr 7:25,949,919...25,949,986
G
MIR149
microRNA 149
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 2:240,456,001...240,456,089
Ensembl chr 2:240,456,001...240,456,089
G
MIR150
microRNA 150
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr19:49,500,785...49,500,868
Ensembl chr19:49,500,785...49,500,868
G
MIR151B
microRNA 151b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr14:100,109,419...100,109,514
Ensembl chr14:100,109,419...100,109,514
G
MIR152
microRNA 152
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:48,037,161...48,037,247
Ensembl chr17:48,037,161...48,037,247
G
MIR155
microRNA 155
treatment
ISO
RGD
PMID:29420849 PMID:26867493 PMID:27673475
RGD:21409750 , RGD:25671474 , RGD:25671463
NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
G
MIR17
microRNA 17
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr13:91,350,605...91,350,688
Ensembl chr13:91,350,605...91,350,688
G
MIR181C
microRNA 181c
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr19:13,874,699...13,874,808
Ensembl chr19:13,874,699...13,874,808
G
MIR188
microRNA 188
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:50,003,503...50,003,588
Ensembl chr X:50,003,503...50,003,588
G
MIR18A
microRNA 18a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr13:91,350,751...91,350,821
Ensembl chr13:91,350,751...91,350,821
G
MIR191
microRNA 191
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 3:49,020,618...49,020,709
Ensembl chr 3:49,020,618...49,020,709
G
MIR192
microRNA 192
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22045675 PMID:25359176 PMID:28483554 PMID:28545106
NCBI chr11:64,891,137...64,891,246
Ensembl chr11:64,891,137...64,891,246
G
MIR193A
microRNA 193a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:31,559,996...31,560,083
Ensembl chr17:31,559,996...31,560,083
G
MIR193B
microRNA 193b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:14,303,967...14,304,049
Ensembl chr16:14,303,967...14,304,049
G
MIR194-1
microRNA 194-1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28844483
NCBI chr 1:220,118,157...220,118,241
Ensembl chr 1:220,118,157...220,118,241
G
MIR19A
microRNA 19a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr13:91,350,891...91,350,972
Ensembl chr13:91,350,891...91,350,972
G
MIR200C
microRNA 200c
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr12:6,963,699...6,963,766
Ensembl chr12:6,963,699...6,963,766
G
MIR203B
microRNA 203b
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:32659284
NCBI chr14:104,117,418...104,117,503
Ensembl chr14:104,117,418...104,117,503
G
MIR21
microRNA 21
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
G
MIR210
microRNA 210
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:568,089...568,198
Ensembl chr11:568,089...568,198
G
MIR217
microRNA 217
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 2:55,982,967...55,983,076
Ensembl chr 2:55,982,967...55,983,076
G
MIR218-1
microRNA 218-1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:30125006
NCBI chr 4:20,528,275...20,528,384
Ensembl chr 4:20,528,275...20,528,384
G
MIR22
microRNA 22
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr17:1,713,903...1,713,987
Ensembl chr17:1,713,903...1,713,987
G
MIR221
microRNA 221
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:45,746,157...45,746,266
Ensembl chr X:45,746,157...45,746,266
G
MIR222
microRNA 222
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:45,747,015...45,747,124
Ensembl chr X:45,747,015...45,747,124
G
MIR223
microRNA 223
ISO
RNA:increased expression:serum,liver
RGD
PMID:28646120
RGD:21408574
NCBI chr X:66,018,870...66,018,979
Ensembl chr X:66,018,870...66,018,979
G
MIR23A
microRNA 23a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr19:13,836,587...13,836,659
Ensembl chr19:13,836,587...13,836,659
G
MIR23B
microRNA 23b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:95,085,208...95,085,304
Ensembl chr 9:95,085,208...95,085,304
G
MIR27B
microRNA 27b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25359176 PMID:28545106
NCBI chr 9:95,085,445...95,085,541
Ensembl chr 9:95,085,445...95,085,541
G
MIR29B2
microRNA 29b-2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 1:207,802,443...207,802,523
Ensembl chr 1:207,802,443...207,802,523
G
MIR29C
microRNA 29c
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106 PMID:30515189
NCBI chr 1:207,801,852...207,801,939
Ensembl chr 1:207,801,852...207,801,939
G
MIR301A
microRNA 301a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:59,151,136...59,151,221
Ensembl chr17:59,151,136...59,151,221
G
MIR30A
microRNA 30a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:25359176 PMID:28545106
NCBI chr 6:71,403,551...71,403,621
Ensembl chr 6:71,403,551...71,403,621
G
MIR30B
microRNA 30b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 8:134,800,520...134,800,607
Ensembl chr 8:134,800,520...134,800,607
G
MIR30C1
microRNA 30c-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 1:40,757,284...40,757,372
Ensembl chr 1:40,757,284...40,757,372
G
MIR320A
microRNA 320a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106 PMID:30125006
NCBI chr 8:22,244,966...22,245,037
Ensembl chr 8:22,244,962...22,245,043
G
MIR328
microRNA 328
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:67,202,321...67,202,395
Ensembl chr16:67,202,321...67,202,395
G
MIR335
microRNA 335
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:130,496,111...130,496,204
Ensembl chr 7:130,496,111...130,496,204
G
MIR337
microRNA 337
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr14:100,874,493...100,874,585
Ensembl chr14:100,874,493...100,874,585
G
MIR338
microRNA 338
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:81,125,883...81,125,949
Ensembl chr17:81,125,883...81,125,949
G
MIR33B
microRNA 33b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:17,813,836...17,813,931
Ensembl chr17:17,813,836...17,813,931
G
MIR342
microRNA 342
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr14:100,109,655...100,109,753
Ensembl chr14:100,109,655...100,109,753
G
MIR345
microRNA 345
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr14:100,307,859...100,307,956
Ensembl chr14:100,307,859...100,307,956
G
MIR34A
microRNA 34a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 1:9,151,668...9,151,777
Ensembl chr 1:9,151,668...9,151,777
G
MIR34C
microRNA 34c
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr11:111,513,439...111,513,515
Ensembl chr11:111,513,439...111,513,515
G
MIR3591
microRNA 3591
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr18:58,451,080...58,451,152
Ensembl chr18:58,451,080...58,451,152
G
MIR361
microRNA 361
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:85,903,636...85,903,707
Ensembl chr X:85,903,636...85,903,707
G
MIR3615
microRNA 3615
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:74,748,613...74,748,699
Ensembl chr17:74,748,613...74,748,699
G
MIR362
microRNA 362
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:50,008,964...50,009,028
Ensembl chr X:50,008,964...50,009,028
G
MIR367
microRNA 367
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr 4:112,647,874...112,647,941
Ensembl chr 4:112,647,874...112,647,941
G
MIR378A
microRNA 378a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 5:149,732,825...149,732,890
Ensembl chr 5:149,732,825...149,732,890
G
MIR378C
microRNA 378c
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr10:130,962,588...130,962,668
Ensembl chr10:130,962,588...130,962,668
G
MIR378I
microRNA 378i
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr22:41,923,222...41,923,297
Ensembl chr22:41,923,222...41,923,297
G
MIR410
microRNA 410
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr14:101,065,912...101,065,991
Ensembl chr14:101,065,912...101,065,991
G
MIR421
microRNA 421
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:74,218,377...74,218,461
Ensembl chr X:74,218,377...74,218,461
G
MIR423
microRNA 423
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:30,117,079...30,117,172
Ensembl chr17:30,117,079...30,117,172
G
MIR4433B
microRNA 4433b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 2:64,340,747...64,340,848
Ensembl chr 2:64,340,747...64,340,848
G
MIR4448
microRNA 4448
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 3:183,886,800...183,886,885
Ensembl chr 3:183,886,800...183,886,885
G
MIR4492
microRNA 4492
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:118,910,708...118,910,787
Ensembl chr11:118,910,708...118,910,787
G
MIR4507
microRNA 4507
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr14:105,858,124...105,858,175
Ensembl chr14:105,858,124...105,858,175
G
MIR4516
microRNA 4516
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:2,133,119...2,133,204
Ensembl chr16:2,133,119...2,133,204
G
MIR452
microRNA 452
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:151,959,628...151,959,712
Ensembl chr X:151,959,628...151,959,712
G
MIR455
microRNA 455
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:114,209,434...114,209,529
Ensembl chr 9:114,209,434...114,209,529
G
MIR483
microRNA 483
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr11:2,134,134...2,134,209
Ensembl chr11:2,134,134...2,134,209
G
MIR484
microRNA 484
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr16:15,643,294...15,643,372
Ensembl chr16:15,643,294...15,643,372
G
MIR497
microRNA 497
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr17:7,017,911...7,018,022
Ensembl chr17:7,017,911...7,018,022
G
MIR499A
microRNA 499a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr20:34,990,376...34,990,497
Ensembl chr20:34,990,376...34,990,497
G
MIR503
microRNA 503
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr X:134,546,328...134,546,398
Ensembl chr X:134,546,328...134,546,398
G
MIR505
microRNA 505
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:139,924,148...139,924,231
Ensembl chr X:139,924,148...139,924,231
G
MIR5196
microRNA 5196
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr19:35,345,513...35,345,627
Ensembl chr19:35,345,513...35,345,627
G
MIR532
microRNA 532
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:50,003,148...50,003,238
Ensembl chr X:50,003,148...50,003,238
G
MIR5588
microRNA 5588
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 3:185,253,210...185,253,272
Ensembl chr 3:185,253,210...185,253,272
G
MIR574
microRNA 574
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 4:38,868,032...38,868,127
Ensembl chr 4:38,868,032...38,868,127
G
MIR589
microRNA 589
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:5,495,819...5,495,917
Ensembl chr 7:5,495,819...5,495,917
G
MIR592
microRNA 592
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:28545106
NCBI chr 7:127,058,088...127,058,184
Ensembl chr 7:127,058,088...127,058,184
G
MIR625
microRNA 625
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr14:65,471,102...65,471,186
Ensembl chr14:65,471,102...65,471,186
G
MIR627
microRNA 627
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr15:42,199,570...42,199,666
Ensembl chr15:42,199,570...42,199,666
G
MIR629
microRNA 629
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr15:70,079,372...70,079,468
Ensembl chr15:70,079,372...70,079,468
G
MIR651
microRNA 651
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:8,126,965...8,127,061
Ensembl chr X:8,126,965...8,127,061
G
MIR660
microRNA 660
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:50,013,241...50,013,337
Ensembl chr X:50,013,241...50,013,337
G
MIR6741
microRNA 6741
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 1:225,922,080...225,922,142
Ensembl chr 1:225,922,080...225,922,142
G
MIR6815
microRNA 6815
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr21:45,478,266...45,478,326
Ensembl chr21:45,478,266...45,478,326
G
MIR6852
microRNA 6852
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:35,710,676...35,710,741
Ensembl chr 9:35,710,676...35,710,741
G
MIR744
microRNA 744
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424 PMID:28545106
NCBI chr17:12,081,899...12,081,996
Ensembl chr17:12,081,899...12,081,996
G
MIR764
microRNA 764
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363424
NCBI chr X:114,639,435...114,639,519
Ensembl chr X:114,639,435...114,639,519
G
MIR766
microRNA 766
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr X:119,646,738...119,646,848
Ensembl chr X:119,646,738...119,646,848
G
MIR7704
microRNA 7704
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 2:176,188,843...176,188,901
Ensembl chr 2:176,188,843...176,188,901
G
MIR7977
microRNA 7977
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 3:176,515,103...176,515,151
Ensembl chr 3:176,515,103...176,515,151
G
MIR877
microRNA 877
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27713024
NCBI chr 6:30,584,332...30,584,417
Ensembl chr 6:30,584,332...30,584,417
G
MIR885
microRNA 885
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 3:10,394,489...10,394,562
Ensembl chr 3:10,394,489...10,394,562
G
MIR93
microRNA 93
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 7:100,093,768...100,093,847
Ensembl chr 7:100,093,768...100,093,847
G
MIR99A
microRNA 99a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr21:16,539,089...16,539,169
Ensembl chr21:16,539,089...16,539,169
G
MIRLET7B
microRNA let-7b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106 PMID:30125006
NCBI chr22:46,113,686...46,113,768
Ensembl chr22:46,113,686...46,113,768
G
MIRLET7C
microRNA let-7c
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr21:16,539,828...16,539,911
Ensembl chr21:16,539,828...16,539,911
G
MIRLET7D
microRNA let-7d
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 9:94,178,834...94,178,920
Ensembl chr 9:94,178,834...94,178,920
G
MIRLET7G
microRNA let-7g
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr 3:52,268,278...52,268,361
Ensembl chr 3:52,268,278...52,268,361
G
MIRLET7I
microRNA let-7i
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28545106
NCBI chr12:62,603,686...62,603,769
Ensembl chr12:62,603,686...62,603,769
G
MMP2
matrix metallopeptidase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15763341
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP9
matrix metallopeptidase 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MST1
macrophage stimulating 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:49,683,947...49,689,474
Ensembl chr 3:49,683,947...49,689,501
G
MST1R
macrophage stimulating 1 receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22575169
NCBI chr 3:49,887,002...49,903,873
Ensembl chr 3:49,886,902...49,903,873
G
MT-ND6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
ISO
mRNA:decreased expression:blood
RGD
PMID:20130021
RGD:8657129
NCBI chr MT:14,149...14,673
Ensembl chr MT:14,149...14,673
G
MTHFR
methylenetetrahydrofolate reductase
treatment
EXP IAGP
CTD Direct Evidence: marker/mechanism associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human)
CTD RGD
PMID:18551038 PMID:19648163 PMID:30545275
RGD:14696733
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
MTPN
myotrophin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:135,926,760...135,977,359
Ensembl chr 7:135,926,760...135,977,359
G
MYD88
MYD88 innate immune signal transduction adaptor
ameliorates
ISO
RGD
PMID:17615358
RGD:150521532
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
G
NAT2
N-acetyltransferase 2
treatment
IAGP EXP
associated with Tuberculosis;DNA:haplotype: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11915035 PMID:16799928 PMID:17950035 PMID:25693865 PMID:18023090
RGD:8552665
NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218
G
NDUFS3
NADH:ubiquinone oxidoreductase core subunit S3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:47,579,074...47,584,562
Ensembl chr11:47,565,336...47,584,562
G
NFATC4
nuclear factor of activated T cells 4
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:34192554
NCBI chr14:24,366,911...24,379,604
Ensembl chr14:24,365,673...24,379,604
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO EXP
induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620) CTD Direct Evidence: therapeutic
CTD RGD
PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 PMID:30215777 PMID:18417483 PMID:31889292 PMID:31927046 PMID:32066295 PMID:31972209 PMID:29091898 More...
RGD:6893370 , RGD:21201308 , RGD:21201305 , RGD:21201283 , RGD:21201280 , RGD:15090820
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NFKB1
nuclear factor kappa B subunit 1
treatment susceptibility
ISO IAGP
associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human)
RGD
PMID:29091898 PMID:31490979
RGD:15090820 , RGD:40902984
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NFXL1
nuclear transcription factor, X-box binding like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 4:47,847,233...47,914,667
Ensembl chr 4:47,847,233...47,914,667
G
NME2
NME/NM23 nucleoside diphosphate kinase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr17:51,165,536...51,171,744
Ensembl chr17:51,165,435...51,171,744
G
NOTCH1
notch receptor 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:30394310
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
G
NOX4
NADPH oxidase 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
RGD
PMID:28522909 PMID:29091898 PMID:28472605
RGD:13439737 , RGD:15090820 , RGD:13439739
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR0B2
nuclear receptor subfamily 0 group B member 2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:29943110
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
NR1D1
nuclear receptor subfamily 1 group D member 1
treatment
ISO
RGD
PMID:24497272
RGD:10448995
NCBI chr17:40,092,793...40,100,589
Ensembl chr17:40,092,793...40,100,589
G
NR1H3
nuclear receptor subfamily 1 group H member 3
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:17256725
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
G
NR1H4
nuclear receptor subfamily 1 group H member 4
treatment severity
EXP ISO
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:liver (rat) protein:decreased expression:liver (rat)
CTD RGD
PMID:12875239 PMID:29091898 PMID:28827769 PMID:30068870 PMID:22711662 PMID:20573685 More...
RGD:15090820 , RGD:15045609 , RGD:15042870 , RGD:14701036 , RGD:14701035
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
G
NR1I2
nuclear receptor subfamily 1 group I member 2
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism|therapeutic associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human)
CTD RGD
PMID:19797606 PMID:28058446 PMID:31490979
RGD:40902984
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
G
NR1I3
nuclear receptor subfamily 1 group I member 3
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:14742670 PMID:25656644 PMID:28058446
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
G
NR2F2
nuclear receptor subfamily 2 group F member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr15:96,326,046...96,340,263
Ensembl chr15:96,325,938...96,340,263
G
NR5A2
nuclear receptor subfamily 5 group A member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29515023
NCBI chr 1:200,027,710...200,177,415
Ensembl chr 1:200,027,614...200,177,420
G
NREP
neuronal regeneration related protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 5:111,728,802...111,976,932
Ensembl chr 5:111,662,621...111,997,464
G
NTN1
netrin 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:35292334
NCBI chr17:9,003,087...9,244,000
Ensembl chr17:9,021,510...9,244,000
G
NUS1
NUS1 dehydrodolichyl diphosphate synthase subunit
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:33812996
NCBI chr 6:117,675,469...117,710,727
Ensembl chr 6:117,675,469...117,710,727
G
OCIAD1
OCIA domain containing 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:48,805,156...48,861,815
Ensembl chr 4:48,805,212...48,861,817
G
OGDH
oxoglutarate dehydrogenase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:44,606,627...44,709,066
Ensembl chr 7:44,606,572...44,709,066
G
OR51E2
olfactory receptor family 51 subfamily E member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:4,680,171...4,697,853
Ensembl chr11:4,680,171...4,697,854
G
P4HB
prolyl 4-hydroxylase subunit beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856
G
PAH
phenylalanine hydroxylase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:102,836,889...102,958,441
Ensembl chr12:102,836,889...102,958,410
G
PAN2
poly(A) specific ribonuclease subunit PAN2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr12:56,316,936...56,334,000
Ensembl chr12:56,316,223...56,334,053
G
PANX1
pannexin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29246445
NCBI chr11:94,128,841...94,181,968
Ensembl chr11:94,128,841...94,181,968
G
PARK7
Parkinsonism associated deglycase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:7,961,711...7,985,505
Ensembl chr 1:7,954,291...7,985,505
G
PC
pyruvate carboxylase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386
G
PCOLCE
procollagen C-endopeptidase enhancer
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:100,602,363...100,608,175
Ensembl chr 7:100,602,363...100,608,175
G
PCYT1A
phosphate cytidylyltransferase 1A, choline
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:196,234,368...196,287,726
Ensembl chr 3:196,214,222...196,287,957
G
PDK4
pyruvate dehydrogenase kinase 4
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21182459 PMID:31809757
NCBI chr 7:95,583,499...95,596,516
Ensembl chr 7:95,583,499...95,596,516
G
PDLIM5
PDZ and LIM domain 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:94,451,942...94,668,223
Ensembl chr 4:94,451,857...94,668,227
G
PEX11A
peroxisomal biogenesis factor 11 alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr15:89,681,535...89,690,754
Ensembl chr15:89,677,764...89,690,783
G
PGM1
phosphoglucomutase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:63,593,411...63,660,245
Ensembl chr 1:63,593,411...63,660,245
G
PLAT
plasminogen activator, tissue type
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
PLG
plasminogen
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr 6:160,702,193...160,754,097
Ensembl chr 6:160,702,194...160,754,097
G
PLS3
plastin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:115,561,174...115,650,861
Ensembl chr X:115,561,174...115,650,861
G
PNP
purine nucleoside phosphorylase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr14:20,469,406...20,477,089
Ensembl chr14:20,461,992...20,477,094
G
PNRC1
proline rich nuclear receptor coactivator 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:89,080,751...89,085,160
Ensembl chr 6:89,080,751...89,085,160
G
POLG
DNA polymerase gamma, catalytic subunit
susceptibility no_association
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human) DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human)
CTD RGD
PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931
RGD:15039302 , RGD:15039297
NCBI chr15:89,316,320...89,334,824
Ensembl chr15:89,305,198...89,334,861
G
POLR2G
RNA polymerase II subunit G
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:62,761,580...62,766,710
Ensembl chr11:62,761,565...62,766,710
G
PON1
paraoxonase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
PPARA
peroxisome proliferator activated receptor alpha
ISO EXP
LPS-induced acute liver damage CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24385052 PMID:38181850 PMID:21262334
RGD:5509941
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:26599535
RGD:11554658
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PPTC7
protein phosphatase targeting COQ7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr12:110,533,245...110,583,318
Ensembl chr12:110,533,245...110,583,318
G
PRKAA1
protein kinase AMP-activated catalytic subunit alpha 1
treatment
ISO
RGD
PMID:29091898
RGD:15090820
NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
G
PRKCD
protein kinase C delta
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:30393195
NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717
G
PRKDC
protein kinase, DNA-activated, catalytic subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21224054
NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178
G
PTF1A
pancreas associated transcription factor 1a
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:21182459
NCBI chr10:23,192,312...23,194,245
Ensembl chr10:23,192,312...23,194,245
G
PTGES2
prostaglandin E synthase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31444509
NCBI chr 9:128,120,693...128,128,440
Ensembl chr 9:128,120,693...128,128,462
G
PTGS2
prostaglandin-endoperoxide synthase 2
treatment
EXP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:11743745 PMID:29091898
RGD:15090820
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PUM1
pumilio RNA binding family member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:30,931,506...31,065,717
Ensembl chr 1:30,931,506...31,065,991
G
PYGL
glycogen phosphorylase L
EXP IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
CTD RGD
PMID:25231249 PMID:25336395
RGD:21079733
NCBI chr14:50,905,217...50,944,483
Ensembl chr14:50,857,891...50,944,483
G
PZP
PZP alpha-2-macroglobulin like
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr12:9,136,472...9,208,395
Ensembl chr12:9,148,840...9,208,395
G
RASA1
RAS p21 protein activator 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:87,267,883...87,391,916
Ensembl chr 5:87,267,883...87,391,931
G
RBP1
retinol binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 3:139,517,438...139,539,742
Ensembl chr 3:139,517,434...139,539,829
G
RDH13
retinol dehydrogenase 13
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27865848
NCBI chr19:55,039,103...55,069,520
Ensembl chr19:55,039,108...55,071,291
G
REEP5
receptor accessory protein 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 5:112,876,385...112,922,227
Ensembl chr 5:112,876,385...112,922,289
G
RGN
regucalcin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr X:47,078,443...47,093,313
Ensembl chr X:47,078,355...47,093,314
G
RIPK3
receptor interacting serine/threonine kinase 3
EXP ISO
CTD Direct Evidence: therapeutic protein:increased expression:liver (mouse)
CTD RGD
PMID:26769846 PMID:28205631
RGD:127229945
NCBI chr14:24,336,025...24,339,991
Ensembl chr14:24,336,025...24,340,022
G
S100A11
S100 calcium binding protein A11
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,506...152,047,907
G
SCARB1
scavenger receptor class B member 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
G
SELENBP1
selenium binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707
G
SEMA3A
semaphorin 3A
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:33290778
NCBI chr 7:83,955,777...84,492,725
Ensembl chr 7:83,955,777...84,492,724
G
SEMA4A
semaphorin 4A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:33290778
NCBI chr 1:156,147,373...156,177,744
Ensembl chr 1:156,147,366...156,177,752
G
SENP2
SUMO specific peptidase 2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:29535048
NCBI chr 3:185,586,295...185,633,551
Ensembl chr 3:185,582,496...185,633,551
G
SERPINA1
serpin family A member 1
susceptibility
ISO IAGP
protein:decreased expression:plasma DNA:missense mutation:cds:p.E264V(human)
RGD
PMID:11140575 PMID:20170533
RGD:1643168 , RGD:14695048
NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693
G
SERPINA6
serpin family A member 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr14:94,304,248...94,323,336
Ensembl chr14:94,304,248...94,323,389
G
SERPINE1
serpin family E member 1
treatment
IAGP
associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human)
RGD
PMID:23183238
RGD:14696750
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SERPING1
serpin family G member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171
G
SESN2
sestrin 2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:28209544
NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491
G
SGF29
SAGA complex associated factor 29
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr16:28,553,920...28,591,790
Ensembl chr16:28,553,915...28,591,790
G
SHC1
SHC adaptor protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249 PMID:32659284
NCBI chr 1:154,962,298...154,974,376
Ensembl chr 1:154,962,298...154,974,395
G
SLC10A1
solute carrier family 10 member 1
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28827769
RGD:15045609
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
G
SLC10A7
solute carrier family 10 member 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 4:146,253,981...146,521,940
Ensembl chr 4:146,253,975...146,522,372
G
SLC13A4
solute carrier family 13 member 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:135,681,231...135,728,186
Ensembl chr 7:135,681,231...135,729,258
G
SLC22A25
solute carrier family 22 member 25
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:63,158,437...63,243,599
Ensembl chr11:63,158,437...63,243,599
G
SLC22A8
solute carrier family 22 member 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
SLC25A29
solute carrier family 25 member 29
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr14:100,278,567...100,306,444
Ensembl chr14:100,291,116...100,306,547
G
SLC7A5
solute carrier family 7 member 5
treatment
ISO
RGD
PMID:9200186
RGD:151357001
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,016...87,869,507
G
SLCO1B1
solute carrier organic anion transporter family member 1B1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32259555
NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796
G
SLPI
secretory leukocyte peptidase inhibitor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
G
SNX18
sorting nexin 18
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 5:54,517,759...54,648,005
Ensembl chr 5:54,517,759...54,546,586
G
SOD1
superoxide dismutase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750 PMID:27349771
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
treatment severity susceptibility
EXP IAGP ISO
CTD Direct Evidence: marker/mechanism associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human) DNA:SNP:cds:p.Val16Ala(human)
CTD RGD
PMID:25226513 PMID:27019981 PMID:19647030 PMID:19332662 PMID:20578157
RGD:11060605 , RGD:26923961 , RGD:26923959 , RGD:26923957
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SOD3
superoxide dismutase 3
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:11529661
NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842
G
SORD
sorbitol dehydrogenase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12763371
NCBI chr15:45,023,195...45,077,185
Ensembl chr15:45,023,147...45,077,185
G
SORL1
sortilin related receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr11:121,452,314...121,633,763
Ensembl chr11:121,452,314...121,633,763
G
SPIN2A
spindlin family member 2A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr X:57,134,265...57,147,180
Ensembl chr X:57,134,530...57,137,523
G
SPP1
secreted phosphoprotein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SRP72
signal recognition particle 72
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 4:56,467,617...56,503,681
Ensembl chr 4:56,467,617...56,503,681
G
STAT3
signal transducer and activator of transcription 3
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:38460807
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
G
STAT4
signal transducer and activator of transcription 4
severity
ISO
protein:increased phosphorylation:liver, inflammatory cell (mouse) mRNA:increased expression:liver, macrophage (mouse)
RGD
PMID:24731448 PMID:23876342
RGD:25671417 , RGD:25671422
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,178,435
G
STING1
stimulator of interferon response cGAMP interactor 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chr 5:139,475,533...139,482,758
Ensembl chr 5:139,475,533...139,482,935
G
SULT1C3
sulfotransferase family 1C member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:108,239,968...108,265,351
Ensembl chr 2:108,239,968...108,265,351
G
SULT1E1
sulfotransferase family 1E member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145
G
SULT2B1
sulfotransferase family 2B member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27052460
NCBI chr19:48,552,172...48,599,427
Ensembl chr19:48,552,172...48,599,425
G
SUOX
sulfite oxidase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:55,997,276...56,005,525
Ensembl chr12:55,997,180...56,006,641
G
TAGLN2
transgelin 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:159,918,111...159,925,507
Ensembl chr 1:159,918,107...159,925,507
G
TALDO1
transaldolase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19436114
NCBI chr11:747,464...765,012
Ensembl chr11:747,415...765,012
G
TBXA2R
thromboxane A2 receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22206755
NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875
G
TCTN1
tectonic family member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr12:110,614,129...110,649,430
Ensembl chr12:110,614,027...110,663,431
G
TF
transferrin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
G
TGFB1
transforming growth factor beta 1
treatment
ISO
RGD
PMID:27516150
RGD:14995464
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFBR1
transforming growth factor beta receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28560358
NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192
G
THBS1
thrombospondin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:35357534
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
G
THPO
thrombopoietin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:33122006
NCBI chr 3:184,371,935...184,379,688
Ensembl chr 3:184,371,935...184,381,968
G
TLR4
toll like receptor 4
disease_progression
ISO
RGD
PMID:17504260
RGD:14697733
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TLR5
toll like receptor 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30508503
NCBI chr 1:223,109,404...223,143,248
Ensembl chr 1:223,109,404...223,143,292
G
TLR9
toll like receptor 9
severity treatment
IEP ISO
protein:increased expression: blood, neutrophil (human)
RGD
PMID:26457748 PMID:19164858 PMID:23509352
RGD:18337465 , RGD:18337476 , RGD:18337473
NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
G
TMED7
transmembrane p24 trafficking protein 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 5:115,613,210...115,626,036
Ensembl chr 5:115,613,210...115,632,992
G
TMEM117
transmembrane protein 117
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr12:43,795,802...44,399,108
Ensembl chr12:43,835,967...44,389,762
G
TMEM164
transmembrane protein 164
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr X:110,002,369...110,184,251
Ensembl chr X:110,002,631...110,184,247
G
TMEM38B
transmembrane protein 38B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 9:105,694,541...105,776,629
Ensembl chr 9:105,694,541...105,776,629
G
TNF
tumor necrosis factor
treatment severity
ISO EXP
CTD Direct Evidence: marker/mechanism|therapeutic protein:increased expression:serum (rat)
CTD RGD
PMID:7532385 PMID:9696492 PMID:17709330 PMID:19638433 PMID:20623750 PMID:21984482 PMID:37866487 PMID:15830285 PMID:29091898 PMID:31342809 PMID:14686721 PMID:10801288 PMID:10801287 PMID:19189285 PMID:17070847 PMID:31077717 PMID:11124822 More...
RGD:10450531 , RGD:15090820 , RGD:15036799 , RGD:14995485 , RGD:14995437 , RGD:14995435 , RGD:14995430 , RGD:14995429 , RGD:14975281 , RGD:14696804
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TRAJ18
T cell receptor alpha joining 18
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chr14:22,525,650...22,525,715
Ensembl chr14:22,525,650...22,525,715
G
TRPM2
transient receptor potential cation channel subfamily M member 2
ISO
RGD
PMID:24569808
RGD:9999438
NCBI chr21:44,353,621...44,442,644
Ensembl chr21:44,350,163...44,443,081
G
TTR
transthyretin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr18:31,591,877...31,598,821
Ensembl chr18:31,557,009...31,598,833
G
TUBA1A
tubulin alpha 1a
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:49,184,795...49,189,080
Ensembl chr12:49,184,686...49,189,324
G
TUBB4B
tubulin beta 4B class IVb
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:137,241,287...137,243,707
Ensembl chr 9:137,241,287...137,243,707
G
UBA5
ubiquitin like modifier activating enzyme 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 3:132,654,430...132,679,794
Ensembl chr 3:132,654,446...132,679,794
G
UGT1A1
UDP glucuronosyltransferase family 1 member A1
susceptibility
IAGP
DNA:SNP:exon (rs4148323)(human)
RGD
PMID:28900877
RGD:14694824
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
G
UGT1A9
UDP glucuronosyltransferase family 1 member A9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
G
UNC93B1
unc-93 homolog B1, TLR signaling regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:67,991,100...68,004,097
Ensembl chr11:67,991,100...68,004,982
G
USP5
ubiquitin specific peptidase 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:6,852,150...6,866,632
Ensembl chr12:6,852,148...6,866,632
G
VEGFA
vascular endothelial growth factor A
treatment
EXP IDA
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25231249 PMID:17784864
RGD:15003197
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VIM
vimentin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
VWF
von Willebrand factor
ISO EXP
protein:increased expression:liver: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28527913 PMID:7531171
RGD:11079232
NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770
G
WASL
WASP like actin nucleation promoting factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:123,681,943...123,749,003
Ensembl chr 7:123,681,943...123,749,003
G
XRCC1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:haploinsufficiency: : (mouse)
RGD
PMID:21737425
RGD:15036796
NCBI chr19:43,543,311...43,575,527
Ensembl chr19:43,543,311...43,580,473
G
XYLB
xylulokinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 3:38,346,785...38,453,041
Ensembl chr 3:38,346,760...38,421,348
G
ZDHHC23
zinc finger DHHC-type palmitoyltransferase 23
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 3:113,947,901...113,979,508
Ensembl chr 3:113,947,901...113,965,401
G
ARRB2
arrestin beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chr17:4,710,632...4,721,497
Ensembl chr17:4,710,596...4,721,499
G
DRD2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
GAD1
glutamate decarboxylase 1
susceptibility
IAGP ISO
associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human) protein:decreased expression:prefrontal cortex
RGD
PMID:27967329 PMID:24200867
RGD:401900122 , RGD:401900162
NCBI chr 2:170,813,210...170,861,151
Ensembl chr 2:170,813,213...170,861,151
G
GAD2
glutamate decarboxylase 2
susceptibility
IAGP
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chr10:26,216,372...26,304,558
Ensembl chr10:26,216,665...26,304,558
G
OPRM1
opioid receptor mu 1
IAGP
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
G
ABAT
4-aminobutyrate aminotransferase
ISO
RGD
PMID:7740056 PMID:6445277
RGD:1598524 , RGD:10047091
NCBI chr16:8,674,617...8,784,570
Ensembl chr16:8,674,596...8,784,575
G
CACNA1D
calcium voltage-gated channel subunit alpha1 D
ISO
RGD
PMID:18947822
RGD:6906919
NCBI chr 3:53,494,611...53,813,733
Ensembl chr 3:53,328,963...53,813,733
G
CAT
catalase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19109989
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCK
cholecystokinin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:2320253
NCBI chr 3:42,257,826...42,266,185
Ensembl chr 3:42,257,825...42,266,185
G
COMT
catechol-O-methyltransferase
ISO
RGD
PMID:16437585
RGD:2289781
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)
IAGP
RGD
PMID:12629505
RGD:1358549
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
DBN1
drebrin 1
ISO
levodopainduced; protein:increased expression:striatum:
RGD
PMID:23241013
RGD:10398811
NCBI chr 5:177,456,610...177,473,634
Ensembl chr 5:177,456,608...177,474,401
G
DDC
dopa decarboxylase
ISO
associated with Parkinson Disease; protein:decreased expression:striatum (rat)
RGD
PMID:20232137
RGD:5128860
NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
G
DRD1
dopamine receptor D1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:7845605 PMID:10858612 PMID:16982285 PMID:19520364
NCBI chr 5:175,440,036...175,444,182
Ensembl chr 5:175,440,036...175,444,182
G
DRD2
dopamine receptor D2
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7845605 PMID:10534246 PMID:14629710 PMID:18707801
RGD:2311579
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
DRD3
dopamine receptor D3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20945430
NCBI chr 3:114,127,580...114,199,407
Ensembl chr 3:114,127,580...114,199,407
G
EGR1
early growth response 1
ISO
RGD
PMID:22153973
RGD:10395307
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
FOSB
FosB proto-oncogene, AP-1 transcription factor subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17219962
NCBI chr19:45,467,996...45,475,179
Ensembl chr19:45,467,995...45,475,179
G
GAD1
glutamate decarboxylase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:9767399
NCBI chr 2:170,813,210...170,861,151
Ensembl chr 2:170,813,213...170,861,151
G
GCH1
GTP cyclohydrolase 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:15659429
NCBI chr14:54,842,017...54,902,826
Ensembl chr14:54,842,008...54,902,826
G
GDNF
glial cell derived neurotrophic factor
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:11168568
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
GLUL
glutamate-ammonia ligase
ISO
RGD
PMID:6445277
RGD:10047091
NCBI chr 1:182,378,098...182,391,790
Ensembl chr 1:182,378,098...182,392,206
G
GRK6
G protein-coupled receptor kinase 6
ISO
associated with Parkinson Disease
RGD
PMID:20410529
RGD:5684919
NCBI chr 5:177,425,523...177,442,891
Ensembl chr 5:177,403,204...177,442,901
G
GSK3B
glycogen synthase kinase 3 beta
treatment
ISO
associated with Parkinsonian Disorders
RGD
PMID:26997328
RGD:13792768
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
HOMER1
homer scaffold protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24126708
NCBI chr 5:79,372,636...79,514,134
Ensembl chr 5:79,372,636...79,514,134
G
HTR1A
5-hydroxytryptamine receptor 1A
ISO
RGD
PMID:21352823
RGD:5683628
NCBI chr 5:63,957,874...63,962,445
Ensembl chr 5:63,957,874...63,962,507
G
MAPT
microtubule associated protein tau
treatment
ISO
associated with Parkinsonian Disorders
RGD
PMID:25511986
RGD:13800920
NCBI chr17:45,894,554...46,028,334
Ensembl chr17:45,894,527...46,028,334
G
MTOR
mechanistic target of rapamycin kinase
treatment
ISO
associated with Parkinsonian Disorders
RGD
PMID:23938307
RGD:10040953
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
PDYN
prodynorphin
treatment severity
EXP ISO
CTD Direct Evidence: marker/mechanism associated with Parkinsonism associated with Parkinsonism;protein:increased expression:striatum
CTD RGD
PMID:9767399 PMID:21737418 PMID:10869049 PMID:17884291 PMID:21737418
RGD:401900134 , RGD:401851046 , RGD:401850563
NCBI chr20:1,978,756...1,994,285
Ensembl chr20:1,978,757...1,994,285
G
PENK
proenkephalin
treatment disease_progression
ISO EXP
mRNA:increased expression:brain:striatum: associated with Parkinsonism associated with Parkinsonism;mRNA:increased expression:striatum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9767399 PMID:20456008 PMID:10869049 PMID:26113400
RGD:10003039 , RGD:401900134 , RGD:401851054
NCBI chr 8:56,440,957...56,446,641
Ensembl chr 8:56,436,674...56,446,671
G
PPP1R1B
protein phosphatase 1 regulatory inhibitor subunit 1B
treatment
ISO
associated with Parkinsonian Disorders
RGD
PMID:27771532
RGD:13514053
NCBI chr17:39,626,707...39,636,624
Ensembl chr17:39,626,740...39,636,626
G
RASGRF1
Ras protein specific guanine nucleotide releasing factor 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:21115823
NCBI chr15:78,959,906...79,090,780
Ensembl chr15:78,959,906...79,090,780
G
RELA
RELA proto-oncogene, NF-kB subunit
ISO
protein:increased expression:nucleus, brain
RGD
PMID:18590723
RGD:2298778
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RGS4
regulator of G protein signaling 4
treatment
ISO
associated with Parkinsonian Disorders
RGD
PMID:24969021
RGD:13524515
NCBI chr 1:163,068,871...163,076,802
Ensembl chr 1:163,068,775...163,076,802
G
RGS9
regulator of G protein signaling 9
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:18160641 PMID:24663062
NCBI chr17:65,137,370...65,227,703
Ensembl chr17:65,100,812...65,227,703
G
TH
tyrosine hydroxylase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:15659429
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
G
ABCC2
ATP binding cassette subfamily C member 2
susceptibility no_association
IAGP
DNA:polymorphisms,haplotype:promoter:g.-1774delG,g.-1549G>A(human) DNA:SNPs:multiple:
RGD
PMID:17502832 PMID:22178260
RGD:14700816 , RGD:14700817
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO
DNA:hypermethylation:promoter
RGD
PMID:23619520
RGD:14700910
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:16140414
RGD:2316848
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
LPAR1
lysophosphatidic acid receptor 1
ISO
protein:increased expression:liver (mouse)
RGD
PMID:12201952
RGD:10054288
NCBI chr 9:110,873,263...111,038,998
Ensembl chr 9:110,873,263...111,038,470
G
MIR22
microRNA 22
ISO
in male; RNA:increased expression:liver:
RGD
PMID:21750200
RGD:14700876
NCBI chr17:1,713,903...1,713,987
Ensembl chr17:1,713,903...1,713,987
G
ABCD1
ATP binding cassette subfamily D member 1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,724,856...153,744,755
Ensembl chr X:153,724,856...153,744,755
G
ARHGAP4
Rho GTPase activating protein 4
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,907,378...153,926,264
Ensembl chr X:153,907,367...153,934,999
G
ATP2B3
ATPase plasma membrane Ca2+ transporting 3
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,517,642...153,582,929
Ensembl chr X:153,517,642...153,582,939
G
ATP6AP1
ATPase H+ transporting accessory protein 1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,428,677...154,436,516
Ensembl chr X:154,428,633...154,436,516
G
AVPR2
arginine vasopressin receptor 2
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,902,625...153,907,166
Ensembl chr X:153,902,531...153,907,166
G
BCAP31
B cell receptor associated protein 31
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,700,492...153,724,387
Ensembl chr X:153,700,492...153,724,565
G
BGN
biglycan
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,494,980...153,509,546
Ensembl chr X:153,494,980...153,509,546
G
BRCC3
BRCA1/BRCA2-containing complex subunit 3
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:155,071,508...155,123,077
Ensembl chr X:155,071,420...155,123,077
G
CCNQ
cyclin Q
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,587,925...153,599,139
Ensembl chr X:153,587,925...153,600,045
G
CLIC2
chloride intracellular channel 2
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:155,276,211...155,334,614
Ensembl chr X:155,276,211...155,334,657
G
CMC4
C-X9-C motif containing 4
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:155,061,622...155,071,136
Ensembl chr X:155,061,622...155,071,136
G
CTAG1A
cancer/testis antigen 1A
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,585,133...154,586,816
Ensembl chr X:154,585,133...154,586,816
G
CTAG1B
cancer/testis antigen 1B
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,617,609...154,619,282
Ensembl chr X:154,617,609...154,619,282
G
CTAG2
cancer/testis antigen 2
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,651,977...154,653,579
Ensembl chr X:154,651,972...154,653,579
G
DKC1
dyskerin pseudouridine synthase 1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,762,864...154,777,689
Ensembl chr X:154,762,742...154,777,689
G
DNASE1L1
deoxyribonuclease 1 like 1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,401,236...154,412,101
Ensembl chr X:154,401,236...154,412,112
G
DUSP9
dual specificity phosphatase 9
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,642,441...153,651,326
Ensembl chr X:153,642,492...153,651,326
G
EMD
emerin
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,379,295...154,381,523
Ensembl chr X:154,379,273...154,381,574
G
F8
coagulation factor VIII
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:154,835,792...155,022,723
Ensembl chr X:154,835,788...155,026,940
G
F8A1
coagulation factor VIII associated 1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:154,886,355...154,888,061
Ensembl chr X:154,886,355...154,888,061
G
FAM3A
FAM3 metabolism regulating signaling molecule A
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,506,171...154,516,232
Ensembl chr X:154,506,159...154,516,242
G
FAM50A
family with sequence similarity 50 member A
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,444,141...154,450,654
Ensembl chr X:154,444,141...154,450,654
G
FLNA
filamin A
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,348,531...154,374,634
Ensembl chr X:154,348,524...154,374,634
G
FUNDC2
FUN14 domain containing 2
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:155,026,844...155,060,304
Ensembl chr X:155,025,980...155,060,304
G
G6PD
glucose-6-phosphate dehydrogenase
EXP IAGP ISS
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency | ClinVar Annotator: match by term: Favism, susceptibility to ClinVar Annotator: match by term: G6PD MINNESOTA ClinVar Annotator: match by term: G6PD A- ClinVar Annotator: match by term: FAVISM, SUSCEPTIBILITY TO ClinVar Annotator: match by term: G6PD MALAGA ClinVar Annotator: match by term: G6PD SANTIAGO DE CUBA ClinVar Annotator: match by term: G6PD SERRES
CTD ClinVar MouseDO
PMID:5448 PMID:16832 PMID:511159 PMID:736032 PMID:835572 PMID:848857 PMID:853376 PMID:1008056 PMID:1270075 PMID:1303173 PMID:1303182 PMID:1459579 PMID:1536798 PMID:1551674 PMID:1562739 PMID:1611091 PMID:1631957 PMID:1805484 PMID:1879833 PMID:1924316 PMID:1945893 PMID:1953767 PMID:1972698 PMID:1978554 PMID:1978555 PMID:1999339 PMID:1999409 PMID:2157298 PMID:2190319 PMID:2222408 PMID:2253938 PMID:2255919 PMID:2263506 PMID:2307454 PMID:2321910 PMID:2393028 PMID:2503817 PMID:2572288 PMID:2602358 PMID:2606066 PMID:2633878 PMID:2836867 PMID:2849540 PMID:2895981 PMID:2912069 PMID:2912886 PMID:3198117 PMID:3201886 PMID:3338798 PMID:3393536 PMID:3446582 PMID:3565372 PMID:3591235 PMID:3740052 PMID:4154774 PMID:4283789 PMID:4359638 PMID:4379606 PMID:4388132 PMID:4392654 PMID:4435794 PMID:4721339 PMID:4837298 PMID:4838696 PMID:4974311 PMID:5081671 PMID:5305539 PMID:5316621 PMID:5369703 PMID:5413384 PMID:5485383 PMID:5641629 PMID:5673160 PMID:5770172 PMID:5775246 PMID:5779160 PMID:5844610 PMID:6015571 PMID:6344088 PMID:6500558 PMID:6698555 PMID:6714978 PMID:6714986 PMID:6805883 PMID:7055648 PMID:7129446 PMID:7160841 PMID:7203486 PMID:7211845 PMID:7327562 PMID:7390473 PMID:7440223 PMID:7577654 PMID:7590755 PMID:7655862 PMID:7789945 PMID:7803800 PMID:7806085 PMID:7825590 PMID:7849299 PMID:7858267 PMID:7870632 PMID:7947239 PMID:7947250 PMID:7949118 PMID:7959686 PMID:7959695 PMID:8118045 PMID:8141125 PMID:8193373 PMID:8241497 PMID:8244337 PMID:8364584 PMID:8370579 PMID:8436389 PMID:8447319 PMID:8471773 PMID:8477268 PMID:8490627 PMID:8533762 PMID:8537082 PMID:8611726 PMID:8807085 PMID:8807321 PMID:8807322 PMID:8813094 PMID:8956035 PMID:9017974 PMID:9192788 PMID:9233561 PMID:9250351 PMID:9290617 PMID:9298828 PMID:9299858 PMID:9332310 PMID:9342374 PMID:9384614 PMID:9410474 PMID:9444913 PMID:9536098 PMID:9589612 PMID:9674740 PMID:9858856 PMID:10192449 PMID:10221015 PMID:10480214 PMID:10502785 PMID:10556177 PMID:10571945 PMID:10627140 PMID:10643148 PMID:10666231 PMID:10734064 PMID:10772881 PMID:10782016 PMID:10916676 PMID:11024211 PMID:11042039 PMID:11112389 PMID:11146567 PMID:11243133 PMID:11261779 PMID:11271380 PMID:11295127 PMID:11379875 PMID:11400791 PMID:11445808 PMID:11484161 PMID:11499668 PMID:11594515 PMID:11601226 PMID:11748843 PMID:11780463 PMID:11793482 PMID:11852882 PMID:11968085 PMID:12028056 PMID:12064901 PMID:12064902 PMID:12064920 PMID:12105841 PMID:12130518 PMID:12187030 PMID:12215013 PMID:12367584 PMID:12497642 PMID:12737938 PMID:12737940 PMID:12768444 PMID:12850494 PMID:14014720 PMID:14278484 PMID:14505231 PMID:14757424 PMID:14757426 PMID:15065213 PMID:15223006 PMID:15315792 PMID:15349799 PMID:15466166 PMID:15502081 PMID:15625830 PMID:15727905 PMID:15766741 PMID:15858258 PMID:15906717 PMID:15914531 PMID:15996881 PMID:16079115 PMID:16088936 PMID:16119988 PMID:16136268 PMID:16143877 PMID:16155737 PMID:16193512 PMID:16329560 PMID:16356170 PMID:16427346 PMID:16461316 PMID:16513531 PMID:16528451 PMID:16601897 PMID:16607506 PMID:16753852 PMID:16777444 PMID:16927025 PMID:16934959 PMID:16944148 PMID:17018380 PMID:17233850 PMID:17524386 PMID:17576681 PMID:17587269 PMID:17611006 PMID:17726510 PMID:17877203 PMID:17959407 PMID:18043863 PMID:18046504 PMID:18056001 PMID:18066402 PMID:18086567 PMID:18177777 PMID:18226470 PMID:18270558 PMID:18329300 PMID:18452027 PMID:18568599 PMID:18627054 PMID:18677765 PMID:19224086 PMID:19396829 PMID:19422023 PMID:19465117 PMID:19589177 PMID:19594365 PMID:19632868 PMID:19846429 PMID:20007901 PMID:20052779 PMID:20085579 PMID:20200584 PMID:20203002 PMID:20236109 PMID:20582980 PMID:20602793 PMID:20621077 PMID:20713184 PMID:20949590 PMID:21063220 PMID:21153663 PMID:21302115 PMID:21397531 PMID:21441392 PMID:21446359 PMID:21479984 PMID:21507207 PMID:21637675 PMID:21677401 PMID:21874587 PMID:21931771 PMID:21989994 PMID:22018328 PMID:22139979 PMID:22164279 PMID:22165289 PMID:22171972 PMID:22237549 PMID:22281021 PMID:22293322 PMID:22307442 PMID:22382802 PMID:22452742 PMID:22552160 PMID:22770933 PMID:22906047 PMID:22906837 PMID:22963789 PMID:22963798 PMID:23006493 PMID:23057857 PMID:23144702 PMID:23365477 PMID:23389243 PMID:23409742 PMID:23479361 PMID:23660394 PMID:23757202 PMID:23926329 PMID:23965028 PMID:24022758 PMID:24033266 PMID:24117340 PMID:24134566 PMID:24365856 PMID:24460025 PMID:24505519 PMID:24551785 PMID:24586352 PMID:24711023 PMID:24787449 PMID:24962355 PMID:25071003 PMID:25141282 PMID:25189226 PMID:25201310 PMID:25326637 PMID:25407525 PMID:25440321 PMID:25536053 PMID:25541721 PMID:25548459 PMID:25741868 PMID:25775246 PMID:25925739 PMID:26060661 PMID:26226515 PMID:26275698 PMID:26479991 PMID:26633385 PMID:26693676 PMID:26823837 PMID:26827633 PMID:26829728 PMID:26990548 PMID:27040960 PMID:27053284 PMID:27213370 PMID:27282571 PMID:27287612 PMID:27408423 PMID:27495838 PMID:27519946 PMID:27535533 PMID:27853304 PMID:27880809 PMID:27884173 PMID:27914961 PMID:27941691 PMID:27980749 PMID:28028996 PMID:28059001 PMID:28195434 PMID:28356147 PMID:28492532 PMID:28512736 PMID:28583873 PMID:28756180 PMID:28824188 PMID:28852037 PMID:29072585 PMID:29138396 PMID:29141760 PMID:29248304 PMID:29300386 PMID:29333274 PMID:29339739 PMID:29396846 PMID:30045279 PMID:30077011 PMID:30096395 PMID:30097005 PMID:30161219 PMID:30314477 PMID:30315739 PMID:30674319 PMID:30988594 PMID:31294066 PMID:31489982 PMID:31525211 PMID:31590661 PMID:31602632 PMID:31609781 PMID:31833391 PMID:31862010 PMID:31863082 PMID:32156605 PMID:32180910 PMID:32387441 PMID:32387609 PMID:32425388 PMID:32641076 PMID:32680472 PMID:32702756 PMID:32860008 PMID:32987391 PMID:33051526 PMID:33069889 PMID:33072997 PMID:33128437 PMID:33413378 PMID:33536406 PMID:33628497 PMID:33636823 PMID:33637102 PMID:33708821 PMID:34007417 PMID:34134107 PMID:34272389 PMID:34532700 PMID:34551338 PMID:34620237 PMID:34643346 PMID:34659341 PMID:34762759 PMID:34773909 PMID:34895177 PMID:34934109 PMID:34966093 PMID:34989400 PMID:35313968 PMID:35384376 PMID:35606495 PMID:35695473 PMID:35753512 PMID:35840819 PMID:35845714 PMID:36089067 PMID:36150187 PMID:36212124 PMID:36212142 PMID:36315991 PMID:36353116 PMID:36681081 PMID:36703223 PMID:36704359 PMID:36949502 PMID:38066190 PMID:38308253 PMID:38645242 PMID:38970298 More...
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GAB3
GRB2 associated binding protein 3
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,675,249...154,751,566
Ensembl chr X:154,675,249...154,751,583
G
GDI1
GDP dissociation inhibitor 1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,437,154...154,443,467
Ensembl chr X:154,436,913...154,443,467
G
H2AB1
H2A.B variant histone 1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:154,884,972...154,885,558
Ensembl chr X:154,884,972...154,885,558
G
HAUS7
HAUS augmin like complex subunit 7
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,447,668...153,495,465
Ensembl chr X:153,447,668...153,495,516
G
HCFC1
host cell factor C1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,947,557...153,971,818
Ensembl chr X:153,947,557...153,971,818
G
IDH3G
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,785,768...153,794,375
Ensembl chr X:153,785,766...153,794,512
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency ClinVar Annotator: match by term: G6PD A-
ClinVar
PMID:1945893 PMID:3198117 PMID:6805883 PMID:7803800 PMID:8244337 PMID:8471773 PMID:9384614 PMID:9536098 PMID:9589612 PMID:10480214 PMID:10502785 PMID:10627140 PMID:11379875 PMID:11601226 PMID:11748843 PMID:11968085 PMID:12064920 PMID:15727905 PMID:16329560 PMID:16427346 PMID:16601897 PMID:16607506 PMID:17576681 PMID:18046504 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19589177 PMID:19846429 PMID:21446359 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:25741868 PMID:28492532 PMID:29300386 PMID:29339739 PMID:30045279 PMID:30315739 PMID:31489982 PMID:31862010 PMID:31863082 PMID:33051526 PMID:33072997 PMID:34620237 PMID:34659341 PMID:34762759 PMID:34895177 PMID:34989400 PMID:35313968 PMID:35384376 PMID:35840819 PMID:36212142 PMID:36353116 More...
NCBI chr X:154,541,238...154,565,046
Ensembl chr X:154,541,199...154,565,046
G
IRAK1
interleukin 1 receptor associated kinase 1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
G
L1CAM
L1 cell adhesion molecule
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,861,514...153,886,173
Ensembl chr X:153,861,514...153,886,173
G
LAGE3
L antigen family member 3
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,477,775...154,479,281
Ensembl chr X:154,477,775...154,479,281
G
LOC107181288
origin of replication in promoter of G6PD
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:25741868 PMID:28492532 PMID:29300386 PMID:34620237
NCBI chr X:154,546,511...154,547,759
G
LOC108281126
G6PD and IKBKG intron CAGE-defined low expression enhancer
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:25741868
NCBI chr X:154,541,534...154,543,269
G
LOC129929052
ATAC-STARR-seq lymphoblastoid silent region 21114
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:29300386 PMID:34620237
NCBI chr X:154,546,728...154,547,287
G
LOC130068881
ATAC-STARR-seq lymphoblastoid active region 30067
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:28492532
NCBI chr X:154,547,728...154,548,007
G
MAGEA1
MAGE family member A1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,179,284...153,183,880
Ensembl chr X:153,179,284...153,183,880
G
MECP2
methyl-CpG binding protein 2
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,021,573...154,097,717
Ensembl chr X:154,021,573...154,137,103
G
MPP1
MAGUK p55 scaffold protein 1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:154,778,684...154,805,485
Ensembl chr X:154,778,684...154,821,007
G
MTCP1
mature T cell proliferation 1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:155,064,034...155,071,136
Ensembl chr X:155,064,034...155,147,937
G
NAA10
N-alpha-acetyltransferase 10, NatA catalytic subunit
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,929,225...153,935,037
Ensembl chr X:153,929,225...153,935,080
G
NSDHL
NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:152,831,063...152,869,729
Ensembl chr X:152,830,967...152,869,729
G
OPN1LW
opsin 1, long wave sensitive
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,144,243...154,159,032
Ensembl chr X:154,144,243...154,159,032
G
OPN1MW
opsin 1, medium wave sensitive
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,182,596...154,196,861
Ensembl chr X:154,182,596...154,196,861
G
OPN1MW2
opsin 1, medium wave sensitive 2
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,219,756...154,233,286
Ensembl chr X:154,219,756...154,233,286
G
PDZD4
PDZ domain containing 4
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,802,166...153,830,544
Ensembl chr X:153,802,166...153,830,565
G
PLXNA3
plexin A3
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,458,281...154,477,779
Ensembl chr X:154,458,281...154,477,779
G
PLXNB3
plexin B3
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,764,249...153,779,341
Ensembl chr X:153,764,196...153,779,346
G
PNCK
pregnancy up-regulated nonubiquitous CaM kinase
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,669,733...153,687,771
Ensembl chr X:153,669,733...153,689,010
G
PNMA3
PNMA family member 3
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,056,470...153,060,462
Ensembl chr X:153,056,409...153,060,467
G
PNMA5
PNMA family member 5
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:152,988,824...152,994,116
Ensembl chr X:152,988,824...152,994,116
G
PNMA6A
PNMA family member 6A
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,072,454...153,075,019
Ensembl chr X:153,072,454...153,075,019
G
PNMA6E
PNMA family member 6E
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,395,639...153,414,004
Ensembl chr X:153,395,639...153,401,392
G
RAB39B
RAB39B, member RAS oncogene family
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:155,258,235...155,264,491
Ensembl chr X:155,258,235...155,264,491
G
RENBP
renin binding protein
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,935,269...153,944,643
Ensembl chr X:153,935,269...153,944,687
G
RPL10
ribosomal protein L10
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,398,065...154,402,339
Ensembl chr X:154,389,955...154,409,168
G
SLC10A3
solute carrier family 10 member 3
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,487,311...154,490,629
Ensembl chr X:154,487,306...154,490,690
G
SLC6A8
solute carrier family 6 member 8
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,687,926...153,696,593
Ensembl chr X:153,687,926...153,696,588
G
SMIM9
small integral membrane protein 9
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:154,823,348...154,834,662
Ensembl chr X:154,823,348...154,834,662
G
SRPK3
SRSF protein kinase 3
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,781,041...153,785,730
Ensembl chr X:153,776,412...153,785,732
G
SSR4
signal sequence receptor subunit 4
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,794,159...153,798,512
Ensembl chr X:153,793,516...153,798,499
G
TAFAZZIN
tafazzin, phospholipid-lysophospholipid transacylase
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,411,539...154,421,726
Ensembl chr X:154,411,524...154,421,726
G
TEX28
testis expressed 28
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,271,265...154,295,211
Ensembl chr X:154,271,265...154,295,853
G
TKTL1
transketolase like 1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,295,795...154,330,350
Ensembl chr X:154,295,795...154,330,350
G
TMEM187
transmembrane protein 187
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:153,972,754...153,983,194
Ensembl chr X:153,972,754...153,983,194
G
TREX2
three prime repair exonuclease 2
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,444,473...153,446,056
Ensembl chr X:153,444,473...153,470,587
G
UBL4A
ubiquitin like 4A
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:9384614 PMID:10480214 PMID:11379875 PMID:11748843 PMID:11968085 PMID:16427346 PMID:16601897 PMID:18177777 PMID:18627054 PMID:19396829 PMID:19846429 PMID:22281021 PMID:22382802 PMID:23409742 PMID:23660394 PMID:24365856 PMID:24962355 PMID:28492532 PMID:35384376 More...
NCBI chr X:154,483,717...154,486,615
Ensembl chr X:154,483,717...154,486,615
G
VBP1
VHL binding protein 1
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:155,197,007...155,239,841
Ensembl chr X:155,197,007...155,239,841
G
ZFP92
ZFP92 zinc finger protein
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,411,472...153,426,481
Ensembl chr X:153,411,472...153,426,481
G
ZNF185
zinc finger protein 185 with LIM domain
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:152,898,067...152,973,481
Ensembl chr X:152,898,067...152,973,481
G
ZNF275
zinc finger protein 275
IAGP
ClinVar Annotator: match by term: Anemia, nonspherocytic hemolytic, due to G6PD deficiency
ClinVar
PMID:18177777 PMID:28492532
NCBI chr X:153,334,153...153,352,926
Ensembl chr X:153,334,147...153,360,110
G
ANK3
ankyrin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr10:60,026,298...60,733,528
Ensembl chr10:60,026,298...60,733,490
G
APOE
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
AVP
arginine vasopressin
ISO
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chr20:3,082,556...3,084,724
Ensembl chr20:3,082,556...3,084,724
G
BPIFA1
BPI fold containing family A member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chr20:33,235,996...33,243,306
Ensembl chr20:33,235,995...33,243,311
G
C3
complement C3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
C5
complement C5
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
G
CAT
catalase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CRHR1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr17:45,784,320...45,835,828
Ensembl chr17:45,784,277...45,835,828
G
DIO3
iodothyronine deiodinase 3
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr14:101,561,495...101,563,452
Ensembl chr14:101,560,139...101,563,452
G
DNMT1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
G
DNMT3B
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
G
DRD2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
EHMT2
euchromatic histone lysine methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 6:31,879,759...31,897,698
Ensembl chr 6:31,879,759...31,897,698
G
GABRB3
gamma-aminobutyric acid type A receptor subunit beta3
treatment sexual_dimorphism
ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 , RGD:405866345
NCBI chr15:26,543,552...26,773,763
Ensembl chr15:26,543,552...26,939,539
G
GABRG2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chr 5:162,067,465...162,155,539
Ensembl chr 5:162,000,057...162,162,977
G
GRIN2B
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 , RGD:13432044
NCBI chr12:13,537,337...13,982,134
Ensembl chr12:13,437,942...13,982,002
G
HDAC2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
G
HDAC4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 2:239,048,168...239,401,649 NCBI chr 2:239,193,331...239,195,457
Ensembl chr 2:239,048,168...239,401,654
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
G
IGF1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF1R
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
MAT2A
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281
G
MECP2
methyl-CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893 PMID:23763370
RGD:11344152 , RGD:13432044
NCBI chr X:154,021,573...154,097,717
Ensembl chr X:154,021,573...154,137,103
G
MIR326
microRNA 326
ISO
miRNA:increases expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr11:75,335,092...75,335,186
Ensembl chr11:75,335,092...75,335,186
G
MIR7-3
microRNA 7-3
ISO
miRNA:increased expression:pituitary gland (rat)
RGD
PMID:28710248
RGD:401960105
NCBI chr19:4,770,670...4,770,779
Ensembl chr19:4,770,670...4,770,779
G
MTR
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278
G
NOS1
nitric oxide synthase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chr12:117,208,142...117,361,626
Ensembl chr12:117,208,142...117,452,170
G
NR3C2
nuclear receptor subfamily 3 group C member 2
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
G
OPRK1
opioid receptor kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chr 8:53,225,724...53,251,637
Ensembl chr 8:53,225,724...53,251,637
G
OPRL1
opioid related nociceptin receptor 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chr20:64,080,082...64,100,643
Ensembl chr20:64,080,082...64,100,643
G
PDYN
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr20:1,978,756...1,994,285
Ensembl chr20:1,978,757...1,994,285
G
PER2
period circadian regulator 2
treatment
IDA
RGD
PMID:31329297
RGD:405878078
NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102
G
PNOC
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chr 8:28,316,988...28,343,351
Ensembl chr 8:28,316,986...28,343,355
G
POMC
proopiomelanocortin
treatment
IDA
RGD
PMID:31329297
RGD:405878078
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
PRL
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 , RGD:401960105
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
G
PTEN
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
RASGRF1
Ras protein specific guanine nucleotide releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr15:78,959,906...79,090,780
Ensembl chr15:78,959,906...79,090,780
G
RPS6KA1
ribosomal protein S6 kinase A1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chr 1:26,529,761...26,575,025
Ensembl chr 1:26,529,761...26,575,030
G
SETD7
SET domain containing 7, histone lysine methyltransferase
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chr 4:139,492,974...139,556,219
Ensembl chr 4:139,495,941...139,606,699
G
SLC25A12
solute carrier family 25 member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr 2:171,783,405...171,894,244
Ensembl chr 2:171,783,405...171,999,859
G
SLC6A4
solute carrier family 6 member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
G
TLR4
toll like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
UBE3A
ubiquitin protein ligase E3A
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chr15:25,333,728...25,439,056
Ensembl chr15:25,333,728...25,439,051
G
RHOA
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
G
ATP5F1E
ATP synthase F1 subunit epsilon
ISO
mRNA:decreased expression:heart, mitochondrion (rat)
RGD
PMID:21251948
RGD:5131501
NCBI chr20:59,025,475...59,032,335
Ensembl chr20:59,025,475...59,032,345
G
ATP5PO
ATP synthase peripheral stalk subunit OSCP
ISO
mRNA:decreased expression:heart, mitochondrion (rat)
RGD
PMID:21251948
RGD:5131501
NCBI chr21:33,903,453...33,915,804
Ensembl chr21:33,903,453...33,915,814
G
CDKN2A
cyclin dependent kinase inhibitor 2A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30259626
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
G
GLI1
GLI family zinc finger 1
ISO
RGD
PMID:25623978
RGD:12879410
NCBI chr12:57,459,785...57,472,268
Ensembl chr12:57,459,785...57,472,268
G
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:25623978
RGD:12879410
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
G
SMO
smoothened, frizzled class receptor
treatment
ISO
RGD
PMID:24388991
RGD:12879411
NCBI chr 7:129,188,633...129,213,545
Ensembl chr 7:129,188,633...129,213,545
G
HP
haptoglobin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21075095
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
RGD
PMID:28921207
RGD:14975164
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
IL16
interleukin 16
ISO
protein:increased expression:brain
RGD
PMID:14698845
RGD:1354526
NCBI chr15:81,182,712...81,314,058
Ensembl chr15:81,159,575...81,314,058
G
DAXX
death domain associated protein
ISO
mRNA:increased expression:liver:
RGD
PMID:17692352
RGD:9587799
NCBI chr 6:33,318,558...33,322,959
Ensembl chr 6:33,318,558...33,323,016
G
KDM3B
lysine demethylase 3B
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:21262293
NCBI chr 5:138,352,685...138,437,027
Ensembl chr 5:138,352,685...138,437,028
G
KDR
kinase insert domain receptor
ISO
RGD
PMID:20058324
RGD:5684396
NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
G
ALAD
aminolevulinate dehydratase
ISO EXP
protein:decreased activity:blood (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21396434 PMID:23792432 PMID:24631795 PMID:16597373 PMID:19647414
RGD:1599014 , RGD:4144142
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
G
GLUL
glutamate-ammonia ligase
ISO
protein:increased expression:stellate ganglion
RGD
PMID:29457680
RGD:401794593
NCBI chr 1:182,378,098...182,391,790
Ensembl chr 1:182,378,098...182,392,206
G
HFE
homeostatic iron regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20659343
NCBI chr 6:26,087,429...26,098,343
Ensembl chr 6:26,087,226...26,098,343
G
MMP9
matrix metallopeptidase 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16700817
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MT4
metallothionein 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19921116
NCBI chr16:56,565,073...56,568,957
Ensembl chr16:56,565,073...56,568,957
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
RGD
PMID:28178683
RGD:13440092
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
QDPR
quinoid dihydropteridine reductase
ISO
protein:increased activity:brain, caudate nucleus (rat)
RGD
PMID:2359144
RGD:5128598
NCBI chr 4:17,486,395...17,512,090
Ensembl chr 4:17,460,261...17,512,206
G
RYR1
ryanodine receptor 1
IEP
mRNA:decreased expression:peripheral blood mononuclear cell
RGD
PMID:30661027
RGD:329812013
NCBI chr19:38,433,691...38,587,564
Ensembl chr19:38,433,691...38,595,273
G
VDR
vitamin D receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20692022 PMID:23433214
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
XPO5
exportin 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28042866
NCBI chr 6:43,522,334...43,576,038
Ensembl chr 6:43,522,334...43,576,038
G
XRCC3
X-ray repair cross complementing 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23803535
NCBI chr14:103,697,617...103,715,451
Ensembl chr14:103,697,609...103,715,504
G
ALAD
aminolevulinate dehydratase
ISO
protein:decreased activity:striatum (rat)
RGD
PMID:18778733
RGD:4144152
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
G
ATP13A2
ATPase cation transporting 13A2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22285144
NCBI chr 1:16,985,958...17,011,928
Ensembl chr 1:16,985,958...17,011,928
G
BNIP3
BCL2 interacting protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19442826
NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12171760
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
HTT
huntingtin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:19845833
NCBI chr 4:3,074,681...3,243,960
Ensembl chr 4:3,041,363...3,243,957
G
IFNG
interferon gamma
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18041089
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL1B
interleukin 1 beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18041089
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
MFN2
mitofusin 2
ISO
protein:decreased expression:striatum (rat)
RGD
PMID:28232070
RGD:12910738
NCBI chr 1:11,980,444...12,013,508
Ensembl chr 1:11,980,181...12,015,211
G
NOS2
nitric oxide synthase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15010209 PMID:22174044
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
PRKN
parkin RBR E3 ubiquitin protein ligase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:20089134
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
G
SLC30A10
solute carrier family 30 member 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28860195 PMID:29429640
NCBI chr 1:219,910,445...219,959,098
Ensembl chr 1:219,685,427...219,959,018
G
SLC31A1
solute carrier family 31 member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22465424
NCBI chr 9:113,221,544...113,264,492
Ensembl chr 9:113,221,544...113,264,492
G
SLC39A14
solute carrier family 39 member 14
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28860195
NCBI chr 8:22,367,278...22,434,129
Ensembl chr 8:22,367,278...22,434,129
G
SLC39A8
solute carrier family 39 member 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29429640
NCBI chr 4:102,251,041...102,345,482
Ensembl chr 4:102,251,080...102,431,258
G
SNCA
synuclein alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23934647
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
G
TNF
tumor necrosis factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18041089
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
APOE
apolipoprotein E
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16891999
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
GPX1
glutathione peroxidase 1
ISO
RGD
PMID:18758054
RGD:7240571
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GPX3
glutathione peroxidase 3
ISO
protein:decreased activity:plasma
RGD
PMID:25975991
RGD:401827854
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
G
ICAM1
intercellular adhesion molecule 1
ISO
protein:increased secretion:serum (rat)
RGD
PMID:20508868
RGD:4145621
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
RGD
PMID:28498799
RGD:13439738
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
CTSB
cathepsin B
ISO
RGD
PMID:18638529
RGD:2315510
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15515958
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
S100B
S100 calcium binding protein B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30076900
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
G
AQP9
aquaporin 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29566083
NCBI chr15:58,138,169...58,185,911
Ensembl chr15:58,138,169...58,185,911
G
IL17A
interleukin 17A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31351185
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
INS
insulin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:26364587
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
G
ALAD
aminolevulinate dehydratase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21439310
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
G
EP300
E1A binding protein p300
ISO
mRNA:increased expression:hippocampus
RGD
PMID:24291742
RGD:9588309
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,510...41,180,077
G
SLC6A1
solute carrier family 6 member 1
ISO
protein:increased expression:brain, synaptosome
RGD
PMID:15149801
RGD:1643208
NCBI chr 3:10,992,748...11,039,247
Ensembl chr 3:10,992,186...11,039,247
G
ACHE
acetylcholinesterase (Yt blood group)
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:3669600 PMID:8359835 PMID:23000449
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
BCHE
butyrylcholinesterase
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:22981459 PMID:22982776 PMID:23044488 PMID:23123253 PMID:23178380 PMID:23220586 PMID:26239905 PMID:31201777 More...
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
GSR
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24188896
RGD:10401876
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
PEPD
peptidase D
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:22982776
NCBI chr19:33,386,950...33,521,791
Ensembl chr19:33,386,950...33,521,823
G
PON1
paraoxonase 1
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:11022865 PMID:20581384 PMID:20981111 PMID:23123254 PMID:24326413 PMID:26340881 PMID:28070599 More...
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
AGER
advanced glycosylation end-product specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AGTR1
angiotensin II receptor type 1
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
AKT1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
APP
amyloid beta precursor protein
treatment
ISO IEP
protein:increased expression:hippocampus protein:increased expression:plasma
RGD
PMID:35317728 PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 , RGD:597931096 , RGD:597830178 , RGD:597830151
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
G
BACE1
beta-secretase 1
treatment
ISO
RGD
PMID:33574912 PMID:30221701
RGD:597830178 , RGD:597931096
NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,259
G
BAX
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BDNF
brain derived neurotrophic factor
treatment
ISO IEP
associated with brain ischemia
RGD
PMID:29571823 PMID:32564283 PMID:30232930 PMID:29065194 PMID:33324197 PMID:29599834 PMID:34964700 More...
RGD:401959211 , RGD:596936414 , RGD:596936243 , RGD:596933096 , RGD:405850212 , RGD:401976548 , RGD:401965400
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
CASP3
caspase 3
treatment
ISO
RGD
PMID:33574912 PMID:30221701
RGD:597830178 , RGD:597931096
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CREB1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:37736695 PMID:36688960
RGD:401959211 , RGD:401960090 , RGD:401959611
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
GDNF
glial cell derived neurotrophic factor
treatment
ISO IEP
protein:decreased expression:hippocampus,urine protein:altered expression:hippocampus, urine associated with rheumatic heart disease;protein:increased expression:serum
RGD
PMID:36688960 PMID:34728231 PMID:29512789 PMID:28918204 PMID:33324197 PMID:25251457 More...
RGD:401959611 , RGD:405866364 , RGD:405850251 , RGD:405850250 , RGD:405850212 , RGD:405849389
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
HMGB1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
IGF1
insulin like growth factor 1
treatment
ISO IEP
mRNA:decreased expression:hippocampus mRNA:decreased expression:plasma
RGD
PMID:35317728 PMID:33574912 PMID:35317728
RGD:597830151 , RGD:597830178 , RGD:597830151
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGFBP7
insulin like growth factor binding protein 7
IEP
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chr 4:57,030,773...57,110,385
Ensembl chr 4:57,030,773...57,110,385
G
IL1B
interleukin 1 beta
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:30221701 PMID:23078219 PMID:33390808 PMID:29571823
RGD:7204702 , RGD:597931096 , RGD:597805826 , RGD:401965467 , RGD:401959211
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
treatment
IDA
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808 PMID:30221701 PMID:28684969
RGD:401965467 , RGD:597931096 , RGD:597538492
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IREB2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chr15:78,437,431...78,501,453
Ensembl chr15:78,437,431...78,501,453
G
MAPK1
mitogen-activated protein kinase 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 , RGD:401960090
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 , RGD:401960090
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MIR320A
microRNA 320a
treatment
ISO IEP
protein:increased expression:plasma
RGD
PMID:35317728 PMID:35317728
RGD:597830151 , RGD:597830151
NCBI chr 8:22,244,966...22,245,037
Ensembl chr 8:22,244,962...22,245,043
G
NGF
nerve growth factor
treatment
ISO IEP IDA
associated with brain ischemia
RGD
PMID:30481505 PMID:29599834 PMID:34964700 PMID:30481505
RGD:401965395 , RGD:401976548 , RGD:401965400 , RGD:401965395
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NR3C1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 , RGD:408364984
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NR3C2
nuclear receptor subfamily 3 group C member 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:33390808
RGD:401965467
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
G
NTRK2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:29065194 PMID:32564283 PMID:30232930
RGD:596933096 , RGD:596936414 , RGD:596936243
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chr 3:138,652,698...138,834,928
Ensembl chr 3:138,652,336...138,834,928
G
TLR2
toll like receptor 2
treatment
ISO
RGD
PMID:32300366 PMID:28684969
RGD:597538486 , RGD:597538492
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
G
TLR4
toll like receptor 4
treatment
ISO
RGD
PMID:32300366 PMID:28684969
RGD:597538486 , RGD:597538492
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:29571823 PMID:23078219 PMID:33390808
RGD:401959211 , RGD:597805826 , RGD:401965467
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
F3
coagulation factor III, tissue factor
ISO
protein:increased expression:lung, skin, plasma
RGD
PMID:24831016
RGD:11341687
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
G
ACHE
acetylcholinesterase (Yt blood group)
disease_progression
IDA
RGD
PMID:8043620
RGD:405855847
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
HTR1A
5-hydroxytryptamine receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chr 5:63,957,874...63,962,445
Ensembl chr 5:63,957,874...63,962,507
G
TPH2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chr12:71,938,845...72,032,440
Ensembl chr12:71,938,845...72,186,618
G
ACE
angiotensin I converting enzyme
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
G
ADORA2A
adenosine A2a receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
G
AKT1
AKT serine/threonine kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
CAMK2B
calcium/calmodulin dependent protein kinase II beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,210,019...44,334,577
G
ESR1
estrogen receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
GRM2
glutamate metabotropic receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chr 3:51,707,068...51,718,613
Ensembl chr 3:51,707,068...51,718,613
G
GSTP1
glutathione S-transferase pi 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15729709
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
HTR1A
5-hydroxytryptamine receptor 1A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chr 5:63,957,874...63,962,445
Ensembl chr 5:63,957,874...63,962,507
G
HTR6
5-hydroxytryptamine receptor 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chr 1:19,664,875...19,680,966
Ensembl chr 1:19,664,875...19,680,966
G
NPY1R
neuropeptide Y receptor Y1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chr 4:163,323,962...163,344,689
Ensembl chr 4:163,323,962...163,344,832
G
OPRM1
opioid receptor mu 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
G
PHB1
prohibitin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chr17:49,404,052...49,414,882
Ensembl chr17:49,404,049...49,414,905
G
PICK1
protein interacting with PRKCA 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chr22:38,057,255...38,075,701
Ensembl chr22:38,056,311...38,075,701
G
RGS9
regulator of G protein signaling 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chr17:65,137,370...65,227,703
Ensembl chr17:65,100,812...65,227,703
G
SLC6A3
solute carrier family 6 member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
G
SNCA
synuclein alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
G
SOD2
superoxide dismutase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
treatment
IAGP
associated with schizophrenia
RGD
PMID:10889552
RGD:1358545
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
DRD3
dopamine receptor D3
IAGP
associated with schizophrenia
RGD
PMID:12960753
RGD:1581250
NCBI chr 3:114,127,580...114,199,407
Ensembl chr 3:114,127,580...114,199,407
G
SOD2
superoxide dismutase 2
IAGP
associated with schizophrenia
RGD
PMID:12960753
RGD:1581250
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
ABCB1
ATP binding cassette subfamily B member 1
susceptibility
IAGP EXP
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:SNP: 3435T>C(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12352921 PMID:17938643
RGD:11081146
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ABCG2
ATP binding cassette subfamily G member 2 (JR blood group)
susceptibility
IAGP
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:SNP: :421C>A(human)
RGD
PMID:17938643
RGD:11081146
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
G
ADCYAP1
adenylate cyclase activating polypeptide 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:29604313
NCBI chr18:904,411...912,172
Ensembl chr18:904,871...912,172
G
ADD3
adducin 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr10:109,996,373...110,135,565
Ensembl chr10:109,996,368...110,135,565
G
ADRA1B
adrenoceptor alpha 1B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19125850
NCBI chr 5:159,865,086...159,989,205
Ensembl chr 5:159,865,080...159,973,012
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
G
BCHE
butyrylcholinesterase
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:21620937
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
BCL2L1
BCL2 like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
CASP3
caspase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21972528
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CAT
catalase
ISO
protein:decreased activity:serum:
RGD
PMID:16938375
RGD:9068882
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCK
cholecystokinin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 3:42,257,826...42,266,185
Ensembl chr 3:42,257,825...42,266,185
G
CD3D
CD3 delta subunit of T-cell receptor complex
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr11:118,338,954...118,342,705
Ensembl chr11:118,334,537...118,342,705
G
CRISPLD2
cysteine rich secretory protein LCCL domain containing 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr16:84,819,985...84,909,508
Ensembl chr16:84,819,985...84,920,768
G
CYP3A5
cytochrome P450 family 3 subfamily A member 5
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:21225912
NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
G
DRD2
dopamine receptor D2
ISO
mRNA:decreased expression:hippocampus (rat)
RGD
PMID:19576243
RGD:2311553
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
EGLN1
egl-9 family hypoxia inducible factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29471019
NCBI chr 1:231,363,756...231,422,287
Ensembl chr 1:231,363,751...231,422,287
G
EPHA4
EPH receptor A4
ISO
RGD
PMID:10336070
RGD:5688752
NCBI chr 2:221,418,027...221,574,202
Ensembl chr 2:221,418,027...221,574,202
G
EPHX1
epoxide hydrolase 1
susceptibility
IAGP
DNA:missense mutation:cds:p.H139R (human)
RGD
PMID:17022435
RGD:5490249
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:19220411
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
G
GABRR2
gamma-aminobutyric acid type A receptor subunit rho2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr 6:89,254,464...89,315,299
Ensembl chr 6:89,254,464...89,315,299
G
GSTM1
glutathione S-transferase mu 1
susceptibility
IAGP
DNA:deletion: :
RGD
PMID:8923609 PMID:27220440
RGD:5490214 , RGD:14700956
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTP1
glutathione S-transferase pi 1
susceptibility
IAGP
DNA:polymorphism: :
RGD
PMID:17022435
RGD:5490249
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
IGF1R
insulin like growth factor 1 receptor
IAGP
DNA: snp: intron: rs1879612: bortezomib induced
RGD
PMID:20864405
RGD:5686413
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:23916895
RGD:7364985
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
LAT
linker for activation of T cells
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr16:28,984,803...28,990,784
Ensembl chr16:28,984,826...28,990,784
G
MTOR
mechanistic target of rapamycin kinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16955484
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
NFE2L2
NFE2 like bZIP transcription factor 2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:20211941
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NLRP3
NLR family pyrin domain containing 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32014472
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
G
NQO1
NAD(P)H quinone dehydrogenase 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:20849151
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
P2RX1
purinergic receptor P2X 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr17:3,896,592...3,916,465
Ensembl chr17:3,896,592...3,916,476
G
PLAT
plasminogen activator, tissue type
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19442825
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
PON1
paraoxonase 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:21329748
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
PRKCD
protein kinase C delta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22512859
NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717
G
PTGES3
prostaglandin E synthase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29471019
NCBI chr12:56,663,349...56,688,284
Ensembl chr12:56,663,341...56,688,408
G
RNASE6
ribonuclease A family member 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr14:20,781,070...20,782,467
Ensembl chr14:20,781,268...20,782,467
G
SLC18A2
solute carrier family 18 member A2
ISO
protein:increased expression:thalamus (rat)
RGD
PMID:19798748
RGD:5130970
NCBI chr10:117,241,114...117,279,430
Ensembl chr10:117,241,093...117,279,430
G
SNHG12
small nucleolar RNA host gene 12
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:35410500
NCBI chr 1:28,578,538...28,582,983
Ensembl chr 1:28,578,536...28,583,132
G
SRSF5
serine and arginine rich splicing factor 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr14:69,767,142...69,772,005
Ensembl chr14:69,726,900...69,772,005
G
ST8SIA1
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr12:22,193,391...22,334,707
Ensembl chr12:22,063,773...22,437,041
G
TGM1
transglutaminase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr14:24,249,114...24,263,177
Ensembl chr14:24,249,114...24,264,432
G
TIMP3
TIMP metallopeptidase inhibitor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19784758
NCBI chr22:32,801,705...32,863,041
Ensembl chr22:32,801,705...32,863,041
G
OXT
oxytocin/neurophysin I prepropeptide
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:292422 PMID:803783 PMID:3923190 PMID:4988877 PMID:5067144 PMID:5493616 PMID:5528113 PMID:7360068 More...
NCBI chr20:3,071,620...3,072,517
Ensembl chr20:3,071,620...3,072,517
G
UTS2
urotensin 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16160878
NCBI chr 1:7,847,612...7,913,249
Ensembl chr 1:7,843,083...7,853,512
G
AVP
arginine vasopressin
IEP
associated with alcohol dependence;protein:increased expression:plasma protein:decreased expression:cerebrospinal fluid
RGD
PMID:7662042 PMID:2425205
RGD:596933082 , RGD:596933106
NCBI chr20:3,082,556...3,084,724
Ensembl chr20:3,082,556...3,084,724
G
POMC
proopiomelanocortin
IEP
protein:increased expression:mammillary body
RGD
PMID:1650797
RGD:407572523
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all